+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 10178

Chapter 10178 contains a list of PDF Full Texts available from EurekaMag.





Lam, D.S.H.; Dias, L.S.; Moore, K.H.; Burcher, E., 2000:
Angiotensin II in child urinary bladder: Functional and autoradiographic studies

O'Mahony, O.A.; Djahanbahkch, O.; Mahmood, T.; Puddefoot, J.R.; Vinson, G.P., 2000:
Angiotensin II in human seminal fluid

Harada, K.; Ohmori, M.; Kitoh, Y.; Sugimoto, K.I.hi; Fujimura, A., 1999:
Angiotensin II in human veins: Development of rapid desensitization and effect of indomethacin

Ichiyanagi, O.; Ishii, K.; Endoh, M., 2002:
Angiotensin II increases L-type Ca2+ current in gramicidin D-perforated adult rabbit ventricular myocytes: comparison with conventional patch-clamp method

di Gioia, C.R.; van de Greef, W.M.; Sperti, G.; Castoldi, G.; Todaro, N.; Ierardi, C.; Pieruzzi, F.; Stella, A., 2001:
Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells

Rupérez, M.; Ruiz-Ortega, M.; Esteban, V.; Lorenzo, O.; Mezzano, S.; Plaza, J.Jose.; Egido, Jús., 2003:
Angiotensin II increases connective tissue growth factor in the kidney

Freudenthaler, S.M.; Schreeb, K.H.; Koerner, T.; Gleiter, C.H., 1999:
Angiotensin II increases erythropoietin production in healthy human volunteers

Hu, Z-Wei.; Kerb, R.; Shi, X-You.; Wei-Lavery, T.; Hoffman, B.B., 2002:
Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells

Rodgers, K.; Xiong, S.; Espinoza, T.; Roda, N.; Maldonado, S.; diZerega, G.S., 2000:
Angiotensin II increases host resistance to peritonitis

Du, J.; Sudo, T.; Sakuma, Y.; Kato, M., 2000:
Angiotensin II increases intracellular Ca2+ concentration in folliculo-stellate cells of the rat anterior pituitary in primary culture

Braileanu, G.T.; Simasko, S.M.; Speth, R.C.; Daubert, D.; Hu, J.; Mirando, M.A., 2002:
Angiotensin II increases intracellular calcium concentration in pig endometrial stromal cells through type 1 angiotensin receptors, but does not stimulate phospholipase C activity or prostaglandin F2alpha secretion

Kim, S.; Whelan, J.; Claycombe, K.; Reath, D.B.; Moustaid-Moussa, N., 2002:
Angiotensin II increases leptin secretion by 3T3-L1 and human adipocytes via a prostaglandin-independent mechanism

Ferrer, M.; Alonso, M.J.sus; Salaices, M.; Marin, J.; Balfagon, G., 2001:
Angiotensin II increases neurogenic nitric oxide metabolism in mesenteric arteries from hypertensive rats

Zhu, M.; Natarajan, R.; Nadler, J.L.; Moore, J.M.; Gelband, C.H.; Sumners, C., 2000:
Angiotensin II increases neuronal delayed rectifier K(+) current: role of 12-lipoxygenase metabolites of arachidonic acid

Lorenzo, O.; Ruiz-Ortega, M.; Esbrit, P.; Rupérez, Mönica.; Ortega, A.; Santos, S.; Blanco, J.; Ortega, L.; Egido, J., 2002:
Angiotensin II increases parathyroid hormone-related protein (PTHrP) and the type 1 PTH/PTHrP receptor in the kidney

Nitschke, R.; Henger, A.; Ricken, S.; Gloy, J.; Müller, V.; Greger, R.; Pavenstädt, H., 2000:
Angiotensin II increases the intracellular calcium activity in podocytes of the intact glomerulus

Ferri, C.; Desideri, G.; Baldoncini, R.; Bellini, C.; Valenti, M.; Santucci, A.; D.M.ttia, G., 1999:
Angiotensin II increases the release of endothelin-1 from human cultured endothelial cells but does not regulate its circulating levels

Wang, Y.X.; Martin-McNulty, B.; Freay, A.D.; Sukovich, D.A.; Halks-Miller, M.; Li, W.W.; Vergona, R.; Sullivan, M.E.; Morser, J.; Dole, W.P.; Deng, G.G., 2001:
Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice

Kato, A.; Klein, J.D.; Zhang, C.; Sands, J.M., 2000:
Angiotensin II increases vasopressin-stimulated facilitated urea permeability in rat terminal IMCDs

Wang, X.; Yang, H.; Raizada, M.K., 2001:
Angiotensin II increases vesicular trafficking in brain neurons

Morawietz, H.; Rueckschloss, U.; Niemann, B.; Duerrschmidt, N.; Galle, J.; Hakim, K.; Zerkowski, H.R.; Sawamura, T.; Holtz, J., 1999:
Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low-density lipoprotein

Ding, G.; Reddy, K.; Kapasi, A.A.; Franki, N.; Gibbons, N.; Kasinath, B.S.; Singhal, P.C., 2002:
Angiotensin II induces apoptosis in rat glomerular epithelial cells

Dendorfer, A.; Thornagel, A.; Raasch, W.; Grisk, O.; Tempel, K.; Dominiak, P., 2002:
Angiotensin II induces catecholamine release by direct ganglionic excitation

Nonaka, H.; Emoto, N.; Ikeda, K.; Fukuya, H.; Rohman, M.S.; Raharjo, S.B.; Yagita, K.; Okamura, H.; Yokoyama, M., 2001:
Angiotensin II induces circadian gene expression of clock genes in cultured vascular smooth muscle cells

Finckenberg, P.; Inkinen, K.; Ahonen, J.; Merasto, S.; Louhelainen, M.; Vapaatalo, H.; Müller, D.; Ganten, D.; Luft, F.; Mervaala, E., 2003 :
Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways

Bataller, R.; Gines, P.; Nicolas, J.M.; Gorbig, M.N.eves; Garcia Ramallo, E.; Gasull, X.; Bosch, J.; Arroyo, V.; Rodes, J., 2000:
Angiotensin II induces contraction and proliferation of human hepatic stellate cells

Otani, A.; Takagi, H.; Oh, H.; Koyama, S.; Honda, Y., 2001:
Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells

Brasier, A.R.; Jamaluddin, M.; Han, Y.; Patterson, C.; Runge, M.S., 2000:
Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor

McKay, S.; de Jongste, J.C.; Saxena, P.R.; Sharma, H.S., 1998:
Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1

Richey, J.M.; Ader, M.; Moore, D.; Bergman, R.N., 1999:
Angiotensin II induces insulin resistance independent of changes in interstitial insulin

Ono, K.; Honda, E.; Inenaga, K., 2001:
Angiotensin II induces inward currents in subfornical organ neurones of rats

Piqueras, L.; Kubes, P.; Alvarez, A.; O'Connor, E.; Issekutz, A.C.; Esplugues, J.V.; Sanz, M.J., 2000:
Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregulation

Kintscher, U.; Wakino, S.; Kim, S.; Fleck, E.; Hsueh, W.A.; Law, R.E., 2001:
Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes

Suzuki, E.; Nishimatsu, H.; Satonaka, H.; Walsh, K.; Goto, A.; Omata, M.; Fujita, T.; Nagai, R.; Hirata, Y., 2002:
Angiotensin II induces myocyte enhancer factor 2- and calcineurin/nuclear factor of activated T cell-dependent transcriptional activation in vascular myocytes

Jamaluddin, M.; Meng, T.; Sun, J.; Boldogh, I.; Han, Y.; Brasier, A.R., 2000:
Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kappaB activation

Wolf, G.; Wenzel, U.; Hannken, T.; Stahl, R.A.K., 2001:
Angiotensin II induces p27Kip1 expression in renal tubules in vivo: Role of reactive oxygen species

Bascands, J.L.; Girolami, J.P.; Troly, M.; Escargueil-Blanc, I.; Nazzal, D.; Salvayre, R.; Blaes, N., 2001:
Angiotensin II induces phenotype-dependent apoptosis in vascular smooth muscle cells

Segawa, M.; Nakao, S.; Ogata, Y.; Sugiya, H.; Furuyama, S., 2003:
Angiotensin II induces prostaglandin E2 release in human gingival fibroblasts

Haugen, E.N.; Croatt, A.J.; Nath, K.A., 2000:
Angiotensin II induces renal oxidant stress in vivo and heme oxygenase-1 in vivo and in vitro

Brink, M.; Price, S.R.; Chrast, J.; Bailey, J.L.; Anwar, A.; Mitch, W.E.; Delafontaine, P., 2001:
Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I

Heeneman, S.; Haendeler, J.; Saito, Y.; Ishida, M.; Berk, B.C., 2000:
Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. Key role for the p66 adaptor protein Shc

Kalra, D.; Sivasubramanian, N.; Mann, D.L., 2002:
Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway

Tummala, P.E.; Chen, X.L.; Sundell, C.L.; Laursen, J.B.; Hammes, C.P.; Alexander, R.W.; Harrison, D.G.; Medford, R.M., 1999:
Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis

Egli, M.; Berger, T.; Imboden, H., 2002:
Angiotensin II influences the hyperpolarization-activated current Ih in neurones of the rat paraventricular nucleus

Stevenson, K.M.; Edgley, A.J.; Bergström, G.; Worthy, K.; Kett, M.M.; Anderson, W.P., 2000:
Angiotensin II infused intrarenally causes preglomerular vascular changes and hypertension

Wenzel, U.O.; Thaiss, F.; Helmchen, U.; Stahl, R.A.K.; Wolf, G., 2002:
Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis

Cohen, E.P.; Fish, B.L.; Moulder, J.E., 1999:
Angiotensin II infusion exacerbates radiation nephropathy

Gossmann, J.; Burkhardt, R.; Harder, S.; Lenz, T.; Sedlmeyer, A.; Klinkhardt, U.; Geiger, H.; Scheuermann, E.H., 2001:
Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway

Moritz, K.; Koukoulas, I.; Albiston, A.; Wintour, E.M., 2000:
Angiotensin II infusion to the midgestation ovine fetus: effects on the fetal kidney

Desideri, G.; Bravi, M.Cristina.; Tucci, M.; Croce, G.; Marinucci, M.Contina.; Santucci, A.; Alesse, E.; Ferri, C., 2003:
Angiotensin II inhibits endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability

Xia, Y.; Wen, H.Y.; Kellems, R.E., 2002:
Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation

Solow, B.T.; Derrien, A.; Smith, J.A.; Jarett, L.; Harada, S., 1999:
Angiotensin II inhibits insulin-induced egr-1 expression in mesangial cells

Senthil, D.; Faulkner, J.L.; Choudhury, G.G.; Abboud, H.E.; Kasinath, B.S., 2001:
Angiotensin II inhibits insulin-stimulated phosphorylation of eukaryotic initiation factor 4E-binding protein-1 in proximal tubular epithelial cells

Kihara, M.; Yabana, M.; Toya, Y.; Kobayashi, S.; Fujita, T.; Iwamoto, T.; Ishigami, T.; Umemura, S., 1999:
Angiotensin II inhibits interleukin-1beta-induced nitric oxide production in cultured rat mesangial cells

Müller, M.W.H.; Todorov, V.; Krämer, B.K.; Kurtz, A., 2002:
Angiotensin II inhibits renin gene transcription via the protein kinase C pathway

Murasawa, S.; Matsubara, H.; Mori, Y.; Masaki, H.; Tsutsumi, Y.; Shibasaki, Y.; Kitabayashi, I.; Tanaka, Y.; Fujiyama, S.; Koyama, Y.; Fujiyama, A.; Iba, S.; Iwasaka, T., 2000:
Angiotensin II initiates tyrosine kinase Pyk2-dependent signalings leading to activation of Rac1-mediated c-Jun NH2-terminal kinase

Hayashi, K.; Miyamoto, A., 1999:
Angiotensin II interacts with prostaglandin F2alpha and endothelin-1 as a local luteolytic factor in the bovine corpus luteum in vitro

Tone, E.; Kunisada, K.; Fujio, Y.; Matsui, H.; Negoro, S.; Oh, H.; Kishimoto, T.; Yamauchi-Takihara, K., 1999:
Angiotensin II interferes with leukemia inhibitory factor-induced STAT3 activation in cardiac myocytes

Tebbs, C.; Pratten, M.K.; Broughton Pipkin, F., 1999:
Angiotensin II is a growth factor in the peri-implantation rat embryo

Deraët, M.; Rihakova, L.; Boucard, A.; Pèrodin, J.; Sauvé, S.; Mathieu, A.P.; Guillemette, G.; Leduc, R.; Lavigne, P.; Escher, E., 2002 :
Angiotensin II is bound to both receptors AT1 and AT2, parallel to the transmembrane domains and in an extended form

Wolf, G., 1998:
Angiotensin II is involved in the progression of renal disease: importance of non-hemodynamic mechanisms

Marshall, R.P.; McAnulty, R.J.; Laurent, G.J., 2000:
Angiotensin II is mitogenic for human lung fibroblasts via activation of the type 1 receptor

Haendeler, J.; Berk, B.C., 2000:
Angiotensin II mediated signal transduction: Important role of tyrosine kinases

Cavadas, C.; Grand, D.; Mosimann, F.; Cotrim, M.D.lce; Ribeiro, C.A.berto Fontes; Brunner, H.R.; Grouzmann, E., 2003:
Angiotensin II mediates catecholamine and neuropeptide Y secretion in human adrenal chromaffin cells through the AT1 receptor

Kubo, T.; Hosokawa, H.; Kambe, T.; Fukumori, R., 2000:
Angiotensin II mediates pressure loading-induced mitogen-activated protein kinase activation in isolated rat aorta

Broome, M.; Aneman, A.; Haney, M.; Haggmark, S.; Johansson, G.; Biber, B., 2000:
Angiotensin II mesenteric and renal vasoregulation: Dissimilar modulatory effects with nitroprusside

Castoldi, G.; di Gioia, C.R.; Pieruzzi, F.; van D.G.eef, W.M.; Busca, G.; Sperti, G.; Stella, A., 2001:
Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo

Mishima, K.; Kato, J.; Kuwasako, K.; Imamura, T.; Kitamura, K.; Eto, T., 2003:
Angiotensin II modulates gene expression of adrenomedullin receptor components in rat cardiomyocytes

Sánchez-Mendoza, A.; López-Sánchez, P.; Vázquez-Cruz, B.; Rios, A.; Martínez-Ayala, S.; Escalante, B., 2000 :
Angiotensin II modulates ion transport in rat proximal tubules through CYP metabolites

Tian, B.; Liu, J.; Bitterman, P.; Bache, R.J., 2003:
Angiotensin II modulates nitric oxide-induced cardiac fibroblast apoptosis by activation of AKT/PKB

Muscella, A.; Aloisi, F.; Marsigliante, S.; Levi, G., 2000:
Angiotensin II modulates the activity of Na+,K+-ATPase in cultured rat astrocytes via the AT1 receptor and protein kinase C-delta activation

Marsigliante, S.; Muscella, A.; Barker, S.; Storelli, C., 2000:
Angiotensin II modulates the activity of the Na+/K+ATPase in eel kidney

Diaz Cabiale, Z.; Fuxe, K.; Covenas, R.; Gonzalez Baron, S.; Narvaez, J.A., 2003:
Angiotensin II modulates the cardiovascular responses to microinjection of NPY Y1 and NPY Y2 receptor agonists into the nucleus tractus solitarii of the rat

Bishop, V.S.; Sanderford, M.G., 2000:
Angiotensin II modulation of the arterial baroreflex: Role of the area postrema

Maturana, A.D.; Casal, A.J.; Demaurex, N.; Vallotton, M.B.; Capponi, A.M.; Rossier, M.F., 1999:
Angiotensin II negatively modulates L-type calcium channels through a pertussis toxin-sensitive G protein in adrenal glomerulosa cells

Suárez, C.; Díaz-Torga, G.; Gonzalez-Iglesias, A.; Vela, J.; Mladovan, A.; Baldi, A.; Becu-Villalobos, D., 2003:
Angiotensin II phosphorylation of extracellular signal-regulated kinases in rat anterior pituitary cells

Hisada, Y.; Sugaya, T.; Yamanouchi, M.; Uchida, H.; Fujimura, H.; Sakurai, H.; Fukamizu, A.; Murakami, K., 1999:
Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice

Fukuda, K.; Izumo, S., 1998 :
Angiotensin II potentiates DNA synthesis in AT-1 transformed cardiomyocytes

Betancourt Calle, S.; Mann Blakeney, R.; Isales, C.M.; Calle, R.A.; Bollag, W.B.llinger, 2001:
Angiotensin II priming of aldosterone secretion with agents that enhance Ca2+ influx

Didion, S.P.; Faraci, F.M., 2003:
Angiotensin II produces superoxide-mediated impairment of endothelial function in cerebral arterioles

Daugherty, A.; Manning, M.W.; Cassis, L.A., 2000:
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice

Malhotra, A.; Kang, B.P.; Cheung, S.; Opawumi, D.; Meggs, L.G., 2001:
Angiotensin II promotes glucose-induced activation of cardiac protein kinase C isozymes and phosphorylation of troponin I

Cherradi, N.; Bideau, M.; Arnaudeau, S.; Demaurex, N.; James, R.W.; Azhar, S.; Capponi, A.M., 2001:
Angiotensin II promotes selective uptake of high density lipoprotein cholesterol esters in bovine adrenal glomerulosa and human adrenocortical carcinoma cells through induction of scavenger receptor class B type I

Cammarota, M.; Bevilaqua, L., R.M.; Dunkley, P., R.; Rostas, J., A.P., 2001:
Angiotensin II promotes the phosphorylation of cyclic AMP-responsive element binding protein (CREB) at Ser133 through an ERK1/2-dependent mechanism

Gondo, N.; Kumagai, K.; Nakashima, H.; Saku, K., 2001:
Angiotensin II provokes cesium-induced ventricular tachyarrhythmias

Shyu, K.G.; Chen, C.C.; Wang, B.W.; Kuan, P., 2001:
Angiotensin II receptor antagonist blocks the expression of connexin43 induced by cyclical mechanical stretch in cultured neonatal rat cardiac myocytes

Kansui, Y.; Fujii, K.; Goto, K.; Abe, I.; Iida, M., 2002:
Angiotensin II receptor antagonist improves age-related endothelial dysfunction

Yuda, A.; Takai, S.; Jin, D.; Sawada, Y.; Nishimoto, M.; Matsuyama, N.; Asada, K.; Kondo, K.; Sasaki, S.; Miyazaki, M., 2000:
Angiotensin II receptor antagonist, L-158,809, prevents intimal hyperplasia in dog grafted veins

Burnier, M.; Brunner, H.R., 2000:
Angiotensin II receptor antagonists

Miyata, T.; D.S.rihou, C.V.n Ypersele; Ueda, Y.; Ichimori, K.; Inagi, R.; Onogi, H.; Ishikawa, N.; Nangaku, M.; Kurokawa, K., 2002:
Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: Biochemical mechanisms

Mimran, A.; Ribstein, J.; Ducailar, G., 1999:
Angiotensin II receptor antagonists and hypertension

Burnier, M.; Brunner, H.R., 1998:
Angiotensin II receptor antagonists in hypertension

Wilson, D.P.; Saward, L.; Zahradka, P.; Cheung, P.K., 1999:
Angiotensin II receptor antagonists prevent neointimal proliferation in a porcine coronary artery organ culture model

Chung, O.; Unger, T., 1999:
Angiotensin II receptor blockade and end-organ protection

Unger, T.; Culman, J.; Gohlke, P., 1998:
Angiotensin II receptor blockade and end-organ protection: pharmacological rationale and evidence

Sharma, A.M.; Maier, T.; Jung, C., 1998:
Angiotensin II receptor blockade and renal protection

Jain, M.; Liao, R.; Ngoy, S.; Whittaker, P.; Apstein, C.S.; Eberli, F.R., 2000:
Angiotensin II receptor blockade attenuates the deleterious effects of exercise training on post-MI ventricular remodelling in rats

Perry, G.J.; Wei, C-Chang.; Hankes, G.H.; Dillon, S.Ray.; Rynders, P.; Mukherjee, R.; Spinale, F.G.; Dell'Italia, L.J., 2002:
Angiotensin II receptor blockade does not improve left ventricular function and remodeling in subacute mitral regurgitation in the dog

Lamparter, S.; Sun, Y.; Weber, K.T., 1999:
Angiotensin II receptor blockade during gestation attenuates collagen formation in the developing rat heart

Mazzolai, L.; Maillard, M.; Rossat, J.; Nussberger, J.; Brunner, H.R.; Burnier, M., 1999:
Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists

Kobayashi, S.; Ishida, A.; Moriya, H.; Mori, N.; Fukuda, T.; Takamura, T., 1999:
Angiotensin II receptor blockade limits kidney injury in two-kidney, one-clip Goldblatt hypertensive rats with special reference to phenotypic changes

Richard, V.; Hogie, M.; Thuillez, C., 2000:
Angiotensin II receptor blockade unmasks a depressor response to endothelin antagonists in rats

Forclaz, A.; Maillard, M.; Nussberger, Jürg.; Brunner, H.R.; Burnier, M., 2003:
Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?

Abdi, R.; Dong, V.M.; Lee, C.J.; Ntoso, K.A.u, 2002:
Angiotensin II receptor blocker-associated angioedema: On the heels of ACE inhibitor angioedema

Warner, K.K.; Visconti, J.A.; Tschampel, M.M., 2000:
Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema

Siragy, Helmy, 1999:
Angiotensin II receptor blockers: Review of the binding characteristics

Acikgoz, B.; Akpinar, G.; Bingol, N.; Usseli, I., 1999:
Angiotensin II receptor content within the circumventricular organs increases after experimental hydrocephalus in rats

Ushio-Fukai, M.; Alexander, R.W.; Akers, M.; Lyons, P.R.; Lassègue, B.; Griendling, K.K., 1999:
Angiotensin II receptor coupling to phospholipase D is mediated by the betagamma subunits of heterotrimeric G proteins in vascular smooth muscle cells

Jimenez, E.; Caro, M.C.; Marsigliante, S.; Montiel, M., 1999:
Angiotensin II receptor internalization and signaling in isolated rat hepatocytes

Moulik, S.; Speth, R.C.; Turner, B.B.; Rowe, B.P., 2002:
Angiotensin II receptor subtype distribution in the rabbit brain

Wheeler Schilling, T.H.; Kohler, K.; Sautter, M.; Guenther, E., 1999:
Angiotensin II receptor subtype gene expression and cellular localization in the retina and non-neuronal ocular tissues of the rat

Schwöbel, J.; Fischer, T.; Lanz, B.; Mohaupt, M., 2000:
Angiotensin II receptor subtypes determine induced NO production in rat glomerular mesangial cells

Malendowicz, S.L.; Ennezat, P.V.; Testa, M.; Murray, L.; Sonnenblick, E.H.; Evans, T.; LeJemtel, T.H., 2000:
Angiotensin II receptor subtypes in the skeletal muscle vasculature of patients with severe congestive heart failure

Yang, X-Ping.; Chiba, S., 2003:
Angiotensin II receptor subtypes involved in the modulation of purinergic and adrenergic vasoconstrictions to periarterial electrical nerve stimulation in the canine splenic artery

Wagner, J.; Gehlen, F.; Ciechanowicz, A.; Ritz, E., 1999:
Angiotensin II receptor type 1 gene expression in human glomerulonephritis and diabetes mellitus

Hoffmann, A.; Cool, D.R., 2003:
Angiotensin II receptor types 1A, 1B, and 2 in murine neuroblastoma Neuro-2a cells

Krämer, C.; Sunkomat, J.; Witte, J.; Luchtefeld, M.; Walden, M.; Schmidt, B.; Tsikas, D.; Böger, R.H.; Forssmann, W-Georg.; Drexler, H.; Schieffer, B., 2002:
Angiotensin II receptor-independent antiinflammatory and antiaggregatory properties of losartan: role of the active metabolite EXP3179

Crandall, D.L.; Armellino, D.C.; Busler, D.E.; McHendry-Rinde, B.; Kral, J.G., 1999:
Angiotensin II receptors in human preadipocytes: role in cell cycle regulation

Allen, A.M.; Macgregor, D.P.; Mckinley, M.J.; Mendelsohn, F.A.O., 1999:
Angiotensin II receptors in the human brain

Kasparov, S.; Butcher, J.W.; Paton, J.F.R., 1998:
Angiotensin II receptors within the nucleus of the solitary tract mediate the developmental attenuation of the baroreceptor vagal reflex in pre-weaned rats

Kaplan, M.; Aviram, M.; Knopf, C.; Keidar, S., 2002:
Angiotensin II reduces macrophage cholesterol efflux: a role for the AT-1 receptor but not for the ABC1 transporter

Tanaka, J.; Kariya, K.; Nomura, M., 2003:
Angiotensin II reduces serotonin release in the rat subfornical organ area

Lanz, B.; Kadereit, B.; Ernst, S.; Shojaati, K.; Causevic, M.; Frey, B.M.; Frey, F.J.; Mohaupt, M.G., 2003:
Angiotensin II regulates 11beta-hydroxysteroid dehydrogenase type 2 via AT2 receptors

Nataraj, C.; Oliverio, M.I.; Mannon, R.B.; Mannon, P.J.; Audoly, L.P.; Amuchastegui, C.S.; Ruiz, P.; Smithies, O.; Coffman, T.M., 1999:
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway

Chodobski, A.; Szymydynger Chodobska, J.; Johanson, C.E., 1999:
Angiotensin II regulates choroid plexus blood flow by interacting with the sympathetic nervous system and nitric oxide

Kubo, A.; Fukuda, N.; Teng, J.; Satoh, C.; Nakayama, M.; Kishioka, H.; Kanmatsuse, K., 2000:
Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR

Zeng, C.; Asico, L.D.; Wang, X.; Hopfer, U.; Eisner, G.M.; Felder, R.A.; Jose, P.A., 2003:
Angiotensin II regulation of AT1 and D3 dopamine receptors in renal proximal tubule cells of SHR

Shihab, F.S.; Bennett, W.M.; Isaac, J.; Yi, H.; Andoh, T.F., 2002:
Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity

Dimitropoulou, C.; White, R.E.; Fuchs, L.; Zhang, H.; Catravas, J.D.; Carrier, G.O., 2001:
Angiotensin II relaxes microvessels via the AT(2) receptor and Ca(2+)-activated K(+) (BK(Ca)) channels

Croft, K.D.; McGiff, J.C.; Sanchez-Mendoza, A.; Carroll, M.A., 2000:
Angiotensin II releases 20-HETE from rat renal microvessels

Berk, B.C., 1999:
Angiotensin II signal transduction in vascular smooth muscle: pathways activated by specific tyrosine kinases

Sayeski, P.P.; Ali, M.S.owkat; Semeniuk, D.J.; Doan, T.N.; Bernstein, K.E., 1998:
Angiotensin II signal transduction pathways

Uchiyama-Tanaka, Y.; Matsubara, H.; Nozawa, Y.; Murasawa, S.; Mori, Y.; Kosaki, A.; Maruyama, K.; Masaki, H.; Shibasaki, Y.; Fujiyama, S.; Nose, A.; Iba, O.; Hasagawa, T.; Tateishi, E.; Higashiyama, S.; Iwasaka, T., 2001:
Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells

Schumacker, P.T., 2002:
Angiotensin II signaling in the brain: compartmentalization of redox signaling?

Natarajan, R.; Scott, S.; Bai, W.; Yerneni, K.K.; Nadler, J., 1999:
Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions

Yin, G.; Yan, C.; Berk, B.C., 2003:
Angiotensin II signaling pathways mediated by tyrosine kinases

Andresen, B.T.; Jackson, E.K.; Romero, G.G., 2001:
Angiotensin II signaling to phospholipase D in renal microvascular smooth muscle cells in SHR

Touyz, R.M.; Deng, L.Y.; He, G.; Wu, X.H.; Schiffrin, E.L., 1999:
Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases

du Cheyron, D.; Chalumeau, C.; Defontaine, N.; Klein, C.; Kellermann, O.; Paillard, M.; Poggioli, J., 2003:
Angiotensin II stimulates NHE3 activity by exocytic insertion of the transporter: role of PI 3-kinase

Clement, S.; Pellieux, C.; Chaponnier, C.; Pedrazzini, T.; Gabbiani, G., 2001:
Angiotensin II stimulates alpha-skeletal actin expression in cardiomyocytes in vitro and in vivo in the absence of hypertension

Tanabe, A.; Naruse, M.; Arai, K.; Naruse, K.; Yoshimoto, T.; Seki, T.; Imaki, T.; Kobayashi, M.; Miyazaki, H.; Demura, H., 1998:
Angiotensin II stimulates both aldosterone secretion and DNA synthesis via type 1 but not type 2 receptors in bovine adrenocortical cells

Lea, J.P.; Jin, S.G.; Roberts, B.R.; Shuler, M.S.; Marrero, M.B.; Tumlin, J.A., 2002:
Angiotensin II stimulates calcineurin activity in proximal tubule epithelia through AT-1 receptor-mediated tyrosine phosphorylation of the PLC-gamma1 isoform

Ford, C.M.; Li, S.; Pickering, J.G., 1999:
Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-beta, and tyrosine phosphorylation

Rossi, F.; Ferraresi, A.; Romagni, P.; Silvestroni, L.; Santiemma, V., 2002:
Angiotensin II stimulates contraction and growth of testicular peritubular myoid cells in vitro

Higashida, H.; Zhang, J.; Hashii, M.; Shintaku, M.; Higashida, C.; Takeda, Y., 2000:
Angiotensin II stimulates cyclic ADP-ribose formation in neonatal rat cardiac myocytes

Pueyo, M.E.; Gonzalez, W.; Nicoletti, A.; Savoie, F.; Arnal, J.F.; Michel, J.B., 2000:
Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress

Wolf, G.; Ziyadeh, F.N.; Stahl, R.A., 1999:
Angiotensin II stimulates expression of transforming growth factor beta receptor type II in cultured mouse proximal tubular cells

Matrougui, K.; Eskildsen-Helmond, Y.E.; Fiebeler, A.; Henrion, D.; Levy, B.I.; Tedgui, A.; Mulvany, M.J., 2000:
Angiotensin II stimulates extracellular signal-regulated kinase activity in intact pressurized rat mesenteric resistance arteries

Brink, M.; Chrast, J.; Price, S.R.; Mitch, W.E.; Delafontaine, P., 1999:
Angiotensin II stimulates gene expression of cardiac insulin-like growth factor I and its receptor through effects on blood pressure and food intake

Sundgren, N.C.; Giraud, G.D.; Stork, P.J.S.; Maylie, J.G.; Thornburg, K.L., 2003:
Angiotensin II stimulates hyperplasia but not hypertrophy in immature ovine cardiomyocytes

Oriji, G.K., 2000:
Angiotensin II stimulates hypertrophic growth of cultured neonatal rat ventricular myocytes: roles of PKC and PGF2alpha

Weisinger, R.S.; Blair West, J.R.; Denton, D.A.; Mcburnie, M.I., 1999:
Angiotensin II stimulates intake of ethanol in C57BL/6J mice

Pastore, L.; Tessitore, A.; Martinotti, S.; Toniato, E.; Alesse, E.; Bravi, M.C.; Ferri, C.; Desideri, G.; Gulino, A.; Santucci, A., 1999:
Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo

Jacobi, J.; Schlaich, M.P.; Delles, C.; Schobel, H.P.; Schmieder, R.E., 1999:
Angiotensin II stimulates left ventricular hypertrophy in hypertensive patients independently of blood pressure

Bell, P.D.; Peti-Peterdi, J., 1999:
Angiotensin II stimulates macula densa basolateral sodium/hydrogen exchange via type 1 angiotensin II receptors

Nadal, J.A.; Scicli, G.M.; Carbini, L.A.; Scicli, A.Guillermo., 2002:
Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-beta and PDGF-BB

Deguchi, J.; Makuuchi, M.; Nakaoka, T.; Collins, T.; Takuwa, Y., 1999:
Angiotensin II stimulates platelet-derived growth factor-B chain expression in newborn rat vascular smooth muscle cells and neointimal cells through Ras, extracellular signal-regulated protein kinase, and c-Jun N-terminal protein kinase mechanisms

Amano, S.; Yamagishi, S.; Inagaki, Y.; Okamoto, T., 2003:
Angiotensin II stimulates platelet-derived growth factor-B gene expression in cultured retinal pericytes through intracellular reactive oxygen species generation

Kim, D.K.; Huh, J.E.; Lee, S.H.; Hong, K.P.; Park, J.E.; Seo, J.D.; Lee, W.R., 1999:
Angiotensin II stimulates proliferation of adventitial fibroblasts cultured from rat aortic explants

Voisin, L.; Larose, L.; Meloche, S., 1999:
Angiotensin II stimulates serine phosphorylation of the adaptor protein Nck: physical association with the serine/threonine kinases Pak1 and casein kinase I

Li, D-Pei.; Chen, S-Rui.; Pan, H-Lin., 2003:
Angiotensin II stimulates spinally projecting paraventricular neurons through presynaptic disinhibition

Figueroa, J.E.; Vijayagopal, P., 2002:
Angiotensin II stimulates synthesis of vascular smooth muscle cell proteoglycans with enhanced low density lipoprotein binding properties

Muscella, A.; Marsigliante, S.; Vilella, S.; Jimenez, E.; Storelli, C., 1999:
Angiotensin II stimulates the Na+/H+ exchanger in human umbilical vein endothelial cells via AT1 receptor

Kamada, Y.; Tamura, S.; Kiso, S.; Fukui, K.; Doi, Y.; Ito, N.; Terui, Y.; Saito, T.; Watanabe, H.; Togashi, H.; Kawata, S.; Matsuzawa, Y., 2003:
Angiotensin II stimulates the nuclear translocation of Smad2 and induces PAI-1 mRNA in rat hepatic stellate cells

Pupilli, C.; Lasagni, L.; Romagnani, P.; Bellini, F.; Mannelli, M.; Misciglia, N.; Mavilia, C.; Vellei, U.; Villari, D.; Serio, M., 1999:
Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells

Seki, T.; Yokoshiki, H.; Sunagawa, M.; Nakamura, M.; Sperelakis, N., 1999:
Angiotensin II stimulation of Ca2+-channel current in vascular smooth muscle cells is inhibited by lavendustin-A and LY-294002

Seshiah, P.N.; Weber, D.S.; Rocic, P.; Valppu, L.; Taniyama, Y.; Griendling, K.K., 2002:
Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators

Robey, R.B.; Ruiz, O.S.; Espiritu, D.J.D.; Ibañez, V.C.; Kear, F.T.; Noboa, O.A.; Bernardo, A.A.; Arruda, J.A.L., 2002:
Angiotensin II stimulation of renal epithelial cell Na/HCO3 cotransport activity: a central role for Src family kinase/classic MAPK pathway coupling

Toto, R., 2001:
Angiotensin II subtype 1 receptor blockers and renal function

Fliser, D.; Haller, H., 2001:
Angiotensin II subtype 1-receptor antagonists in the treatment of diabetic nephropathy

Cui, T-Xing.; Nakagami, H.; Nahmias, C.; Shiuchi, T.; Takeda-Matsubara, Y.; Li, J-Mei.; Wu, L.; Iwai, M.; Horiuchi, M., 2002:
Angiotensin II subtype 2 receptor activation inhibits insulin-induced phosphoinositide 3-kinase and Akt and induces apoptosis in PC12W cells

Hropot, M.; Langer, K.H.; Wiemer, G.; Grötsch, H.; Linz, W., 2003:
Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats

Uehara, Y.; Hirawa, N.; Kawabata, Y.; Numabe, A.; Gomi, T.; Ikeda, T.; Omata, M., 1999:
Angiotensin II subtype-1 receptor antagonists improve hemodynamic and renal changes without affecting glucose metabolisms in genetic rat model of non-insulin-dependent diabetes mellitus

Brunet de la Grange, P.; Ivanovic, Z.; Leprivey-Lorgeot, Vérie.; Praloran, V., 2002:
Angiotensin II that reduces the colony-forming ability of hematopoietic progenitors in serum free medium has an inverse effect in serum-supplemented medium

Che, Q.; Carmines, P.K., 2002:
Angiotensin II triggers EGFR tyrosine kinase-dependent Ca2+ influx in afferent arterioles

Holgado, R.; Anaya, F.; Del Castillo, D., 2001:
Angiotensin II type 1 (AT1) receptor antagonists in the treatment of hypertension after renal transplantation

Vag, J.; Keremi, B.; Hably, C.; Bartha, J.; Fazekas, A., 2002:
Angiotensin II type 1 (AT1) receptor blockade enhances the L-NAME-induced vasoconstriction in rat submandibular gland

Malmqvist, K.; Kahan, T.; Dahl, M., 2000:
Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: Benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide

Yoshida, J.; Yamamoto, K.; Mano, T.; Sakata, Y.; Nishikawa, N.; Miwa, T.; Hori, M.; Masuyama, T., 2003:
Angiotensin II type 1 and endothelin type A receptor antagonists modulate the extracellular matrix regulatory system differently in diastolic heart failure

Miura, S.; Karnik, S.S., 1999:
Angiotensin II type 1 and type 2 receptors bind angiotensin II through different types of epitope recognition

Van Geel, P.P.ul; Pinto, Y.M.; Voors, A.A.; Buikema, H.; Oosterga, M.; Crijns, H.J.G.M.; Van Gilst, W.H., 2000:
Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries

Gardemann, A.; Nguyen, Q.D.; Humme, J.; Stricker, J.; Katz, N.; Tillmanns, H.; Hehrlein, F.W.; Rau, M.; Haberbosch, W., 1998:
Angiotensin II type 1 receptor A1166C gene polymorphism. Absence of an association with the risk of coronary artery disease and myocardial infarction and of a synergistic effect with angiotensin-converting enzyme gene polymorphism on the risk of these diseases

Schubert, B.; Fassnacht, M.; Beuschlein, F.; Zenkert, S.; Allolio, B.; Reincke, M., 2001:
Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms

Wassmann, S.; Hilgers, S.; Laufs, U.; Böhm, M.; Nickenig, G., 2002:
Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction

Khalil, A.; Tullus, K.; Bakhiet, M.; Burman, L.G.; Jaremko, G.; Brauner, A., 2000:
Angiotensin II type 1 receptor antagonist (losartan) down-regulates transforming growth factor-beta in experimental acute pyelonephritis

Tsutamoto, T.; Wada, A.; Maeda, K.; Mabuchi, N.; Hayashi, M.; Tsutsui, T.; Ohnishi, M.; Sawaki, M.; Fujii, M.; Matsumoto, T.; Kinoshita, M., 2000:
Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

Fujii, K.; Umemoto, S.; Fujii, A.; Yonezawa, T.; Sakumura, T.; Matsuzaki, M., 1999:
Angiotensin II type 1 receptor antagonist downregulates nonmuscle myosin heavy chains in spontaneously hypertensive rat aorta

Jover, B.; Demeilliers, B., 2000:
Angiotensin II type 1 receptor antagonist versus angiotensin I-converting enzyme inhibitor in experimental renal diseases

Miyazaki, M.; Shiota, N.; Sakonjo, H.; Takai, S., 1999:
Angiotensin II type 1 receptor antagonist, TCV-116, prevents neointima formation in injured arteries in the dog

Shibasaki, Y.; Masaki, H.; Nishiue, T.; Nishikawa, M.; Matsubara, H.; Iwasaka, T., 2002:
Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease

Proudfoot, J.M.; Croft, K.D.; Puddey, I.B.; Beilin, L.J., 2003:
Angiotensin II type 1 receptor antagonists inhibit basal as well as low-density lipoprotein and platelet-activating factor-stimulated human monocyte chemoattractant protein-1

Vanderheyden, P.M.L.; Fierens, F.L.P.; Vauquelin, G., 2000:
Angiotensin II type 1 receptor antagonists: Why do some of them produce insurmountable inhibition?

Gelband, C.H.; Reaves, P.Y.; Evans, J.; Wang, H.; Katovich, M.J.; Raizada, M.K., 1999:
Angiotensin II type 1 receptor antisense gene therapy prevents altered renal vascular calcium homeostasis in hypertension

Suga, S-Ichi.; Mazzali, M.; Ray, P.E.; Kang, D-Hee.; Johnson, R.J., 2002:
Angiotensin II type 1 receptor blockade ameliorates tubulointerstitial injury induced by chronic potassium deficiency

Madeddu, P.; Emanueli, C.; Maestri, R.; Salis, M.B.; Minasi, A.; Capogrossi, M.C.; Olivetti, G., 2000:
Angiotensin II type 1 receptor blockade prevents cardiac remodeling in bradykinin B(2) receptor knockout mice

Hilgers, K.F.; Hartner, A.; Porst, M.; Veelken, R.; Mann, J.F., 2001:
Angiotensin II type 1 receptor blockade prevents lethal malignant hypertension: relation to kidney inflammation

Tazawa, S.; Nakane, T.; Chiba, S., 1999:
Angiotensin II type 1 receptor blockade prevents up-regulation of angiotensin II type 1A receptors in rat injured artery

Martinez, Y.; Martinez, S.; Meaney, A.; Meaney, E.; Escalante, B., 2002:
Angiotensin II type 1 receptor blockade restores nitric oxide-dependent renal vascular responses in renovascular hypertension

Riveiro, A.; Mosquera, A.; Alonso, M.; Calvo, C., 2002:
Angiotensin II type 1 receptor blocker irbesartan ameliorates vascular function in spontaneously hypertensive rats regardless of oestrogen status

Tachikawa, H.; Kodama, M.; Hui, L.; Yoshida, T.; Hayashi, M.; Abe, S.; Kashimura, T.; Kato, K.; Hanawa, H.; Watanabe, K.; Nakazawa, M.; Aizawa, Y., 2003:
Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis

Gross, C.Michael.; Gerbaulet, S.; Quensel, C.; Krämer, J.; Mittelmeier, H-Otto.; Luft, F.C.; Dietz, R., 2002:
Angiotensin II type 1 receptor expression in human coronary arteries with variable degrees of atherosclerosis

Fujimoto, Y.; Sasaki, T.; Tsuchida, A.; Chayama, K., 2001:
Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist

Tanabe, A.; Naruse, M.; Naruse, K.; Ito, F.; Yoshimoto, T.; Seki, T.; Demura, R.; Demura, H.; Toma, H.; Inagami, T., 1999:
Angiotensin II type 1 receptor expression in two cases of juxtaglomerular cell tumor: correlation to negative feedback of renin secretion by angiotensin II

Chou, H-Tai.; Shi, Y-Ru.; Wu, J-Yuarn.; Tsai, F-Jen., 2002:
Angiotensin II type 1 receptor gene adenine/cytosine1166 polymorphism is not associated with mitral valve prolapse syndrome in Taiwan Chinese

Stankovic, A.; Zivkovic, M.; Glisic, S.; Alavantic, D., 2003:
Angiotensin II type 1 receptor gene polymorphism and essential hypertension in Serbian population

Szombathy, T.; Janoskuti, L.; Szalai, C.; Csaszar, A.; Miklosi, M.; Meszaros, Z.; Kempler, P.; Laszlo, Z.; Fenyvesi, T.; Romics, L., 2000:
Angiotensin II type 1 receptor gene polymorphism and mitral valve prolapse syndrome

Miller, J.A.; Thai, K.; Scholey, J.W., 2000:
Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes

Buraczynska, M.; Ksiazek, P.; Zaluska, W.; Spasiewicz, D.; Nowicka, T.; Ksiazek, A., 2002:
Angiotensin II type 1 receptor gene polymorphism in end-stage renal disease

Henrion, D.; Amant, C.; Benessiano, J.; Philip, I.; Plantefève, G.; Chatel, D.; Hwas, U.; Desmont, J.M.; Durand, G.; Amouyel, P.; Lévy, B.I., 1998 :
Angiotensin II type 1 receptor gene polymorphism is associated with an increased vascular reactivity in the human mammary artery in vitro

Miller, J.A.; Thai, K.; Scholey, J.W., 1999:
Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II

Bai Huai; Liu Rui; Liu Xinghui; Liu Yu; L.M.nshu; Liu Bingwen, 2002:
Angiotensin II type 1 receptor gene variations in Chinese pregnancy induced hypertension

Eto, H.; Biro, S.; Miyata, M.; Kaieda, H.; Obata, H.; Kihara, T.; Orihara, K.; Tei, C., 2003:
Angiotensin II type 1 receptor participates in extracellular matrix production in the late stage of remodeling after vascular injury

Hindorff, L.A.; Heckbert, S.R.; Tracy, R.; Tang, Z.; Psaty, B.M.; Edwards, K.L.; Siscovick, D.S.; Kronmal, R.A.; Nazar Stewart, V., 2002:
Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events

Staufenberger, S.; Jacobs, M.; Brandstätter, K.; Hafner, M.; Regitz-Zagrosek, V.; Ertl, G.; Schorb, W., 2001:
Angiotensin II type 1 receptor regulation and differential trophic effects on rat cardiac myofibroblasts after acute myocardial infarction

Lajemi, M.; Labat, C.; Gautier, S.; Lacolley, P.; Safar, M.; Asmar, R.; Cambien, F.; Benetos, A., 2001:
Angiotensin II type 1 receptor-153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects

Miura, S.I.hiro; Zhang, J.; Karnik, S.S., 2000:
Angiotensin II type 1 receptor-function affected by mutations in cytoplasmic loop CD

Kuwahara, M.; Miyaji, T.; Tsubone, H.; Kuwahara, M., 2000:
Angiotensin II type 1 receptor-mediated increase in cytosolic Ca2+ and proliferation in mesothelial cells

Gelband, C.H.; Warth, J.D.; Mason, H.S.; Zhu, M.; Moore, J.M.; Kenyon, J.L.; Horowitz, B.; Sumners, C., 1999:
Angiotensin II type 1 receptor-mediated inhibition of K+ channel subunit kv2.2 in brain stem and hypothalamic neurons

Yanagitani, Y.; Rakugi, H.; Okamura, A.; Moriguchi, K.; Takiuchi, S.; Ohishi, M.; Suzuki, K.; Higaki, J.; Ogihara, T., 1999:
Angiotensin II type 1 receptor-mediated peroxide production in human macrophages

Richards, E.M.; Raizada, M.K.; Gelband, C.H.; Sumners, C., 1999:
Angiotensin II type 1 receptor-modulated signaling pathways in neurons

Hou, M.; Pantev, E.; Möller, S.; Erlinge, D.; Edvinsson, L., 2000:
Angiotensin II type 1 receptors stimulate protein synthesis in human cardiac fibroblasts via a Ca2+-sensitive PKC-dependent tyrosine kinase pathway

Harada, K.; Sugaya, T.; Murakami, K.; Yazaki, Y.; Komuro, I., 1999:
Angiotensin II type 1A receptor knockout mice display less left ventricular remodeling and improved survival after myocardial infarction

Matsubara, H., 2002:
Angiotensin II type 2 (AT2) receptor signal and cardiovascular action

Bartunek, J.; Weinberg, E.O.; Tajima, M.; Rohrbach, S.; Lorell, B.H., 1999:
Angiotensin II type 2 receptor blockade amplifies the early signals of cardiac growth response to angiotensin II in hypertrophied hearts

Takekoshi, K.; Ishii, K.; Shibuya, S.; Kawakami, Y.; Isobe, K.; Nakai, T., 2002:
Angiotensin II type 2 receptor counter-regulates type 1 receptor in catecholamine synthesis in cultured porcine adrenal medullary chromaffin cells

Adachi, Y.; Saito, Y.; Kishimoto, I.; Harada, M.; Kuwahara, K.; Takahashi, N.; Kawakami, R.; Nakanishi, M.; Nakagawa, Y.; Tanimoto, K.; Saitoh, Y.; Yasuno, S.; Usami, S.; Iwai, M.; Horiuchi, M.; Nakao, K., 2003 :
Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice

Yoneda, A.; Cascio, S.; Green, A.; Barton, D.; Puri, P., 2002:
Angiotensin II type 2 receptor gene is not responsible for familial vesicoureteral reflux

Jin, X-Qing.; Fukuda, N.; Su, J-Zi.; Lai, Y-Mu.; Suzuki, R.; Tahira, Y.; Takagi, H.; Ikeda, Y.; Kanmatsuse, K.; Miyazaki, H., 2002:
Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells

Shibasaki, Y.; Matsubara, H.; Nozawa, Y.; Mori, Y.; Masaki, H.; Kosaki, A.; Tsutsumi, Y.; Uchiyama, Y.; Fujiyama, S.; Nose, A.; Iba, O.; Tateishi, E.; Hasegawa, T.; Horiuchi, M.; Nahmias, C.; Iwasaka, T., 2001:
Angiotensin II type 2 receptor inhibits epidermal growth factor receptor transactivation by increasing association of SHP-1 tyrosine phosphatase

Benndorf, R.; Böger, R.H.; Ergün, Süleyman.; Steenpass, A.; Wieland, T., 2003:
Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells

Ichihara, S.; Senbonmatsu, T.; Price, E.; Ichiki, T.; Gaffney, F.A.; Inagami, T., 2001:
Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension

Tsutsumi, Y.; Matsubara, H.; Masaki, H.; Kurihara, H.; Murasawa, S.; Takai, S.; Miyazaki, M.; Nozawa, Y.; Ozono, R.; Nakagawa, K.; Miwa, T.; Kawada, N.; Mori, Y.; Shibasaki, Y.; Tanaka, Y.; Fujiyama, S.; Koyama, Y.; Fujiyama, A.; Takahashi, H.; Iwasaka, T., 1999:
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation

Yang, Z.; Bove, C.M.; French, B.A.; Epstein, F.H.; Berr, S.S.; DiMaria, J.M.; Gibson, J.J.; Carey, R.M.; Kramer, C.M., 2002:
Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction

Shenoy, U.V.; Richards, E.M.; Huang, X.C.; Sumners, C., 1999:
Angiotensin II type 2 receptor-mediated apoptosis of cultured neurons from newborn rat brain

Deinum, J.; van Gool, J.M.; Kofflard, M.J.; ten Cate, F.J.; Danser, A.H., 2001:
Angiotensin II type 2 receptors and cardiac hypertrophy in women with hypertrophic cardiomyopathy

Mifune, M.; Sasamura, H.; Shimizu-Hirota, R.; Miyazaki, H.; Saruta, T., 2000:
Angiotensin II type 2 receptors stimulate collagen synthesis in cultured vascular smooth muscle cells

Bautista, R.; Sánchez, A.; Hernández, J.; Oyekan, A.; Escalante, B., 2001:
Angiotensin II type AT(2) receptor mRNA expression and renal vasodilatation are increased in renal failure

Miyajima, A.; Kosaka, T.; Asano, T.; Asano, T.; Seta, K.; Kawai, T.; Hayakawa, M., 2002:
Angiotensin II type I antagonist prevents pulmonary metastasis of murine renal cancer by inhibiting tumor angiogenesis

Nagamatsu, T.; Hayashi, K.; Oka, T.; Suzuki, Y., 1999:
Angiotensin II type I receptor antagonist suppresses proteinuria and glomerular lesions in experimental nephritis

Touyz, R.M.; Mercure, C.; Reudelhuber, T.L., 2001:
Angiotensin II type I receptor modulates intracellular free Mg2+ in renally derived cells via Na+-dependent Ca2+-independent mechanisms

Kee, F.; Morrison, C.; Poirier, O.; Mccrum, E.; Mallet, C.; Nicaud, V.; Mcmaster, D.; Dallongeville, J.; Fruchart, J.C.; Evans, A.E., 2000:
Angiotensin II type-I receptor and ACE polymorphisms and risk of myocardial infarction in men and women

Fukuda, N.; Hu, W.Y.; Kubo, A.; Kishioka, H.; Satoh, C.; Soma, M.; Izumi, Y.; Kanmatsuse, K., 2000:
Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells

Li, D.; Chen, H.; Mehta, J.L., 2001:
Angiotensin II via activation of type 1 receptor upregulates expression of endoglin in human coronary artery endothelial cells

Wilkes, B.C.; Masaro, L.; Schiller, P.W.; Carpenter, K.A., 2002:
Angiotensin II vs its type I antagonists: Conformational requirements for receptor binding assessed from NMR spectroscopic and receptor docking experiments

Wolf, G.; Harendza, S.; Schroeder, R.; Wenzel, U.; Zahner, G.; Butzmann, U.; Freeman, R.S.; Stahl, R.A.K., 2002:
Angiotensin II's antiproliferative effects mediated through AT2-receptors depend on down-regulation of SM-20

Schnee, J.M.; Hsueh, W.A., 2000:
Angiotensin II, adhesion, and cardiac fibrosis

Berk, B.C.; Haendeler, J.; Sottile, J., 2000:
Angiotensin II, atherosclerosis, and aortic aneurysms

Bataineh, A.; Raij, L., 1998:
Angiotensin II, nitric oxide, and end-organ damage in hypertension

Suzuki, Y.; Ruiz-Ortega, M.; Gomez-Guerrero, C.; Tomino, Y.; Egido, J., 2003:
Angiotensin II, the immune system and renal diseases: another road for RAS?

Hohenfellner, K.; Hunley, T.E.; Yerkes, E.; Habermehl, P.; Hohenfellner, R.; Kon, V., 1999:
Angiotensin II, type 2 receptor in the development of vesico-ureteric reflux

Mori, T.; Cowley, A.W., 2003:
Angiotensin II-NAD(P)H oxidase-stimulated superoxide modifies tubulovascular nitric oxide cross-talk in renal outer medulla

Bruemmer, D.; Collins, A.R.; Noh, G.; Wang, W.; Territo, M.; Arias-Magallona, S.; Fishbein, M.C.; Blaschke, F.; Kintscher, U.; Graf, K.; Law, R.E.; Hsueh, W.A., 2003:
Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice

Blaschke, F.; Stawowy, P.; Kappert, K.; Goetze, S.; Kintscher, U.; Wollert-Wulf, B.; Fleck, E.; Graf, K., 2002:
Angiotensin II-augmented migration of VSMCs towards PDGF-BB involves Pyk2 and ERK 1/2 activation

Belova, L.A., 2000:
Angiotensin II-generating enzymes

Loutzenhiser, K.; Loutzenhiser, R., 2000:
Angiotensin II-induced Ca(2+) influx in renal afferent and efferent arterioles: differing roles of voltage-gated and store-operated Ca(2+) entry

Oriji, G.K., 1999:
Angiotensin II-induced ET and PGI2 release in rat aortic endothelial cells is meditated by PKC

Goldenberg, I.; Grossman, E.; Jacobson, K.A.; Shneyvays, V.; Shainberg, A., 2001:
Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors

Cobb, C.S.; Williamson, R.; Brown, J.A., 1999:
Angiotensin II-induced calcium signalling in isolated glomeruli from fish kidney (Oncorhynchus mykiss) and effects of losartan

Kagiyama, S.; Eguchi, S.; Frank, G.D.; Inagami, T.; Zhang, Y.Clare.; Phillips, M.Ian., 2002:
Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense

Pellieux, C.; Sauthier, T.; Aubert, J.F.; Brunner, H.R.; Pedrazzini, T., 2000:
Angiotensin II-induced cardiac hypertrophy is associated with different mitogen-activated protein kinase activation in normotensive and hypertensive mice

Ikeda, Y.; Nakamura, T.; Takano, H.; Kimura, H.; Obata, J.E.; Takeda, S.; Hata, A.; Shido, K.; Mochizuki, S.; Yoshida, Y., 2000:
Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats

Vyas, S.J.; Blaschak, C.M.; Chinoy, M.R.; Jackson, E.K., 2000:
Angiotensin II-induced changes in G-protein expression and resistance of renal microvessels in young genetically hypertensive rats

Kulkarni, P.S.; Hamid, H.; Barati, M.; Butulija, D., 1999:
Angiotensin II-induced constrictions are masked by bovine retinal vessels

Stanke-Labesque, F.; Devillier, P.; Bedouch, P.; Cracowski, J.L.; Chavanon, O.; Bessard, G., 2000:
Angiotensin II-induced contractions in human internal mammary artery: effects of cyclooxygenase and lipoxygenase inhibition

Kopnisky, K.L.; Sumners, C., 2000:
Angiotensin II-induced decrease in expression of inducible nitric oxide synthase in rat astroglial cultures: Role of protein kinase C

Grippo, A.J.; Kirby, R.F.; Beltz, T.G.; Johnson, A.K.m, 2002:
Angiotensin II-induced drinking and pressor responses to central or systemic irbesartan and losartan

Mangiarua, E.I.; Galagedera, N.J.; Eastham, L.L., 2002:
Angiotensin II-induced growth effects in vascular smooth muscle in cell culture and in the aortic tunica media in organ culture

Bokemeyer, D.; Schmitz, U.; Kramer, H.J., 2000:
Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor

Muthalif, M.M.; Karzoun, N.A.; Gaber, L.; Khandekar, Z.; Benter, I.F.; Saeed, A.E.; Parmentier, J.H.; Estes, A.; Malik, K.U., 2000:
Angiotensin II-induced hypertension: contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites

Ikegami, H.; Endoh, T.; Suzuki, T., 2001:
Angiotensin II-induced inhibition of calcium currents in hamster submandibular ganglion neurons

Yamada, E.; Endoh, T.; Suzuki, T., 2002:
Angiotensin II-induced inhibition of calcium currents via Gq/11-protein involving protein kinase C in hamster submandibular ganglion neurons

Abe, M.; Endoh, T.; Suzuki, T., 2003:
Angiotensin II-induced ionic currents and signalling pathways in submandibular ganglion neurons

Itoh, T.; Kajikuri, J.; Tada, T.; Suzuki, Y.; Mabuchi, Y., 2003:
Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries

Zhang, X.; O'malley, Y.; Robbins, M.E.C., 1999:
Angiotensin II-induced modulation of rat mesangial cell phenotype

Bealer, S.L.; Crowley, W.R., 2003:
Angiotensin II-induced release of oxytocin: interaction with norepinephrine and role in lactation

Jackson, E.K.; Herzer, W.A.; Vyas, S.J.; Kost, C.K., 1999:
Angiotensin II-induced renal vasoconstriction in genetic hypertension

Schmitz, U.; Thömmes, K.; Beier, I.; Wagner, W.; Sachinidis, A.; Düsing, R.; Vetter, H., 2001:
Angiotensin II-induced stimulation of p21-activated kinase and c-Jun NH2-terminal kinase is mediated by Rac1 and Nck

Moriguchi, Y.; Matsubara, H.; Mori, Y.; Murasawa, S.; Masaki, H.; Maruyama, K.; Tsutsumi, Y.; Shibasaki, Y.; Tanaka, Y.; Nakajima, T.; Oda, K.; Iwasaka, T., 1999:
Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-beta synthesis via transcriptional and posttranscriptional mechanisms

Guillemot, L.; Levy, A.; Raymondjean, M.; Rothhut, B., 2001:
Angiotensin II-induced transcriptional activation of the cyclin D1 gene is mediated by Egr-1 in CHO-AT(1A) cells

Venema, R.C.; Venema, V.J.; Eaton, D.C.; Marrero, M.B., 1998:
Angiotensin II-induced tyrosine phosphorylation of signal transducers and activators of transcription 1 is regulated by Janus-activated kinase 2 and Fyn kinases and mitogen-activated protein kinase phosphatase 1

Rössig, L.; Hermann, C.; Haendeler, J.; Assmus, B.; Zeiher, A.M.; Dimmeler, S., 2002:
Angiotensin II-induced upregulation of MAP kinase phosphatase-3 mRNA levels mediates endothelial cell apoptosis

Li-Ji-Cheng; Shen-Yi; Tota, B.; Zummo, G., 2002:
Angiotensin II-induced vascular endothelial growth factor regulates pericardial lymphatic stomata and mesothelial sinusoid in European edible frog (Rana esculenta)

Franca, L.P.; Pacheco, N.A.S.; Correa, S.A.A.; Han, S.W.; Nakaie, C.R.; Paiva, A.C.M.; Shimuta, S.I., 2003:
Angiotensin II-mediated cellular responses: A role for the 3'-untranslated region of the angiotensin AT1 receptor

Hannken, T.; Schroeder, R.; Stahl, R.A.; Wolf, G., 1998:
Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals

Garg, R.; Pandey, K.N., 2003:
Angiotensin II-mediated negative regulation of Npr1 promoter activity and gene transcription

Pitt, C.M.; Nally, J.E., 1999:
Angiotensin II-mediated potentiation of endothelin-1-evoked bronchial contractions: a role for leukotrienes?

Cheng, H.S.; So, S.C.; Law, S.H.; Chan, H.C., 1999:
Angiotensin II-mediated signal transduction events in cystic fibrosis pancreatic duct cells

Inagami, T.; Eguchi, S., 2000:
Angiotensin II-mediated vascular smooth muscle cell growth signaling

Kim, S.; Dugail, I.; Standridge, M.; Claycombe, K.; Chun, J.; Moustaïd-Moussa, N., 2001:
Angiotensin II-responsive element is the insulin-responsive element in the adipocyte fatty acid synthase gene: role of adipocyte determination and differentiation factor 1/sterol-regulatory-element-binding protein 1c

Hunt, R.A.; Bhat, G.J.; Baker, K.M., 1999:
Angiotensin II-stimulated induction of sis-inducing factor is mediated by pertussis toxin-insensitive G(q) proteins in cardiac myocytes

Hill-Kapturczak, N.; Kapturczak, M.H.; Block, E.R.; Patel, J.M.; Malinski, T.; Madsen, K.M.; Tisher, C.C., 1999:
Angiotensin II-stimulated nitric oxide release from porcine pulmonary endothelium is mediated by angiotensin IV

Irani, K., 2001:
Angiotensin II-stimulated vascular remodeling: the search for the culprit oxidase

Yamagishi, S.; Amano, S.; Inagaki, Y.; Okamoto, T.; Inoue, H.; Takeuchi, M.; Choei, H.; Sasaki, N.; Kikuchi, S., 2003:
Angiotensin II-type 1 receptor interaction upregulates vascular endothelial growth factor messenger RNA levels in retinal pericytes through intracellular reactive oxygen species generation

Speth, R.C.; Daubert, D.L.; Grove, K.L., 1999:
Angiotensin II: A reproductive hormone too?

Taubman, M.B., 2003:
Angiotensin II: a vasoactive hormone with ever-increasing biological roles

Wolf, G., 1998:
Angiotensin II:A pivotal factor in the progression of renal diseases

Lorenzo, O.; Ruiz-Ortega, M.; Suzuki, Y.; Rupérez, Mónica.; Esteban, V.; Sugaya, T.; Egido, Jús., 2002:
Angiotensin III activates nuclear transcription factor-kappaB in cultured mesangial cells mainly via AT(2) receptors: studies with AT(1) receptor-knockout mice

Rowe, B.P.; Dixon, B., 2000:
Angiotensin III depressor action in the conscious rabbit is blocked by losartan but not PD 123319

Ruiz-Ortega, M.; Lorenzo, O.; Egido, J., 2000:
Angiotensin III increases MCP-1 and activates NF-kappaB and AP-1 in cultured mesangial and mononuclear cells

Ruiz Ortega, M.; Lorenzo, O.; Egido, J., 1998:
Angiotensin III up-regulates genes involved in kidney damage in mesangial cells and renal interstitial fibroblasts

Reaux, A.; Fournie Zaluski, M.C.aude; Llorens Cortes, C., 2001:
Angiotensin III: A central regulator of vasopressin release and blood pressure

Wayner, M.J.; Armstrong, D.L.; Phelix, C.F.; Wright, J.W.; Harding, J.W., 2001:
Angiotensin IV enhances LTP in rat dentate gyrus in vivo

Slinker, B.K.; Wu, Y.; Brennan, A.J.; Campbell, K.B.; Harding, J.W., 1999:
Angiotensin IV has mixed effects on left ventricle systolic function and speeds relaxation

von Bohlen und Halbach, O., 2002:
Angiotensin IV in the central nervous system

Caron, A.Z.; Arguin, G.; Guillemette, G., 2003 :
Angiotensin IV interacts with a juxtamembrane site on AT4/IRAP suggesting an allosteric mechanism of enzyme modulation

Gesualdo, L.; Ranieri, E.; Monno, R.; Rossiello, M.R.; Colucci, M.; Semeraro, N.; Grandaliano, G.; Schena, F.P.; Ursi, M.; Cerullo, G., 1999:
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells

Chen, S.; Patel, J.M.; Block, E.R., 2000:
Angiotensin IV-mediated pulmonary artery vasorelaxation is due to endothelial intracellular calcium release

Accorsi-Mendonça, D.; Corrêa, F.M.A.; Anselmo-Franci, J.A.; Paiva, T.B.; de Oliveira, A.M., 2002:
Angiotensin actions on the isolated rat uterus during the estrous cycle: influence of resting membrane potential and uterine morphology

Lumbers, Eugenie Ruth, 1999:
Angiotensin and aldosterone

Anderson, W Gary; Cerra, M.C.; Wells, A.; Tierney, M.L.; Tota, B.; Takei, Y.; Hazon, N., 2001:
Angiotensin and angiotensin receptors in cartilaginous fishes

Head, G.A.; Saigusa, T.; Mayorov, D.N., 2002:
Angiotensin and baroreflex control of the circulation

Suarez, C.; Tornadu, I.G.rcia; Cristina, C.; Vela, J.; Iglesias, A.G.nzalez; Libertun, C.; Diaz Torga, G.; Becu Villalobos, D., 2002:
Angiotensin and calcium signaling in the pituitary and hypothalamus

Saavedra, J.M.; Nishimura, Y., 1999:
Angiotensin and cerebral blood flow

Stoll, M.; Unger, T., 2001:
Angiotensin and its AT2 receptor: New insights into an old system

Osborn, J.W.; Collister, J.P.; Carlson, S.H., 2000:
Angiotensin and osmoreceptor inputs to the area postrema: Role in long-term control of fluid homeostasis and arterial pressure

Vaughan, Douglas, E., 2002:
Angiotensin and vascular fibrinolytic balance

Omura, T.; Yoshiyama, M.; Takeuchi, K.; Kim, S.; Iwao, H.; Yamagishi, H.; Toda, I.; Teragaki, M.; Akioka, K.; Yoshikawa, J., 2000:
Angiotensin blockade inhibits SIF DNA binding activities via STAT3 after myocardial infarction

Sharma, A.M.; Janke, Jürgen.; Gorzelniak, K.; Engeli, S.; Luft, F.C., 2002:
Angiotensin blockade prevents type 2 diabetes by formation of fat cells

Morgan, T.O.; Delbridge, L.M., 1999:
Angiotensin blocking drugs and the heart beyond 2000

Kopp, U.C.; Cicha, M.Z.; Smith, L.A., 2003:
Angiotensin blocks substance P release from renal sensory nerves by inhibiting PGE2-mediated activation of cAMP

Ustündağ, B.; Canatan, H.; Cinkilinç, N.; Halifeoğlu, I.; Bahçecioğlu, I.H., 2000:
Angiotensin converting enzyme (ACE) activity levels in insulin-independent diabetes mellitus and effect of ACE levels on diabetic patients with nephropathy

Petrie, M., C.; Padmanabhan, N.; Mcdonald, J., E.; Hillier, C.; Connell, J., M.C.; Mcmurray, J., J.V., 2001:
Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease

Papadopoulos, K.I.; Melander, O.; Orho-Melander, M.; Groop, L.C.; Carlsson, M.; Hallengren, B., 2000:
Angiotensin converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune diseases

Prisco, D.; Fatini, C.; Battaglini, B.; Gensini, F.; Fedi, S.; Falai, M.; Chioccioli, M.; Gori, A.M.; Margheri, M.; Gensini, G.F., 2000:
Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients

Rice, G.I.; Foy, C.A.; Grant, P.J., 1999:
Angiotensin converting enzyme and angiotensin II type 1-receptor gene polymorphisms and risk of ischaemic heart disease

Alvarez, R.; Alvarez, V.; Lahoz, C.H.; Martínez, C.; Peña, J.; Sánchez, J.M.; Guisasola, L.M.; Salas-Puig, J.; Morís, G.; Vidal, J.A.; Ribacoba, R.; Menes, B.B.; Uría, D.; Coto, E., 1999:
Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease

Palumbo, B.; Cadini, D.; Nocentini, G.; Filipponi, E.; Fravolini, M.L.; Senin, U., 1999:
Angiotensin converting enzyme deletion allele in different kinds of dementia disorders

A.E.sa, A.; Haider, M.Z.; Srivastva, B.S., 2001:
Angiotensin converting enzyme gene insertion/deletion polymorphism in idiopathic nephrotic syndrome in Kuwaiti Arab children

Taittonen, L.; Uhari, M.; Kontula, K.; Kainulainen, K.; Miettinen, H.; Turtinen, J.; Nuutinen, M., 1999:
Angiotensin converting enzyme gene insertion/deletion polymorphism, angiotensinogen gene polymorphisms, family history of hypertension, and childhood blood pressure

Segman, R.H.; Shapira, Y.; Modai, I.; Hamdan, A.; Zislin, J.; Heresco Levy, U.; Kanyas, K.; Hirschmann, S.; Karni, O.; Finkel, B.; Schlafman, M.; Lerner, A.; Shapira, B.; Macciardi, F.; Lerer, B., 2002:
Angiotensin converting enzyme gene insertion/deletion polymorphism: Case-control association studies in schizophrenia, major affective disorder, and tardive dyskinesia and a family-based association study in schizophrenia

Bedir, A.; Arik, N.; Adam, B.; Kilinc, K.; Gumus, T.; Guner, E., 1999:
Angiotensin converting enzyme gene polymorphism and activity in Turkish patients with essential hypertension

Holmer, S.R.; Bickeboeller, H.; Hengstenberg, C.; Rohlmann, F.; Engel, S.; Loewel, H.; Mayer, B.; Erdmann, J.; Baier, C.; Klein, G.; Riegger, G.A.J.; Schunkert, H., 2003:
Angiotensin converting enzyme gene polymorphism and myocardial infarction a large association and linkage study

Joseph, A.; Nair, K.G.; Ashavaid, T.F., 1998:
Angiotensin converting enzyme gene polymorphism in coronary artery disease: the Indian scenario

Ohtomo, Y.; Nagaoka, R.; Kaneko, K.; Fukuda, Y.; Miyano, T.; Yamashiro, Y., 2001:
Angiotensin converting enzyme gene polymorphism in primary vesicoureteral reflux

Kurland, L.; Melhus, H.; Karlsson, J.; Kahan, T.; Malmqvist, K.; Ohman, K.P.; Nyström, F.; Hägg, A.; Lind, L., 2001:
Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients

Zaman, M.M.; Yoshiike, N.; Date, C.; Yokoyama, T.; Matsumura, Y.; Ikemoto, S.; Tanaka, H., 2001:
Angiotensin converting enzyme genetic polymorphism is not associated with hypertension in a cross-sectional sample of a Japanese population: the Shibata Study

Barceló, A.; Elorza, M.A.; Barbé, F.; Santos, C.; Mayoralas, L.R.; Agusti, A.G., 2001:
Angiotensin converting enzyme in patients with sleep apnoea syndrome: plasma activity and gene polymorphisms

Hogeboom van Buggenum, I.M.; Polak, B.C.P.; Reichert-Thoen, J.W.M.; de Vries-Knoppert, W.A.E.J.; van Hinsbergh, V.W.M.; Tangelder, G.J., 2002:
Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy

Mosterd, A.; Reitsma, J.B.; Grobbee, D.E., 2002:
Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: The end of an epidemic?

Derad, I.; Dendorfer, A.; Dominiak, P.; Fehm, H.L.; Born, J., 1998:
Angiotensin converting enzyme inhibition by captopril influences cardiac work in healthy hearts

Choi, J.Hoon.; Yoo, K.Hwan.; Cheon, H.Won.; Kim, K.Burm.; Hong, Y.Sook.; Lee, J.Won.; Kim, S.Kyum.; Kim, C.Hwan., 2002:
Angiotensin converting enzyme inhibition decreases cell turnover in the neonatal rat heart

Raasch, W.; Betge, S.; Dendorfer, A.; Bartels, T.; Dominiak, P., 2001:
Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats

Lin, J.; Valeri, A.M.; Markowitz, G.S.; D'Agati, V.D.; Cohen, D.J.; Radhakrishnan, J., 2002:
Angiotensin converting enzyme inhibition in chronic allograft nephropathy

Squire, Iain, B., 2002:
Angiotensin converting enzyme inhibition in heart failure: Clinical trials and clinical practice

Manschot, S.M.; Biessels, G.J.n; Cameron, N.E.; Cotter, M.A.; Kamal, A.; Kappelle, L.J.ap; Gispen, W.H.ndrik, 2003:
Angiotensin converting enzyme inhibition partially prevents deficits in water maze performance, hippocampal synaptic plasticity and cerebral blood flow in streptozotocin-diabetic rats

Sousa, T.; Morato, M.; Albino Teixeira, A., 2002:
Angiotensin converting enzyme inhibition prevents trophic and hypertensive effects of an antagonist of adenosine receptors

Gilbert, R.E.; Kelly, D.J.; Cox, A.J.; Wilkinson-Berka, J.L.; Rumble, J.R.; Osicka, T.; Panagiotopoulos, S.; Lee, V.; Hendrich, E.C.; Jerums, G.; Cooper, M.E., 2000:
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes

Rumble, J.R.; Gilbert, R.E.; Cox, A.; Wu, L.; Cooper, M.E., 1998 :
Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-beta1 and type IV collagen in diabetic vasculopathy

Zucchetta, P.; Carasi, C.; Marzola, M.C.istina; Murer, L.; Passerini Glazel, G.; Rigamonti, W.; Zacchello, G.; Bui, F.; Montini, G., 2001:
Angiotensin converting enzyme inhibition worsens the excretory phase of diuretic renography for obstructive hydronephrosis

Komajda, M.; Wimart, M.C., 2000:
Angiotensin converting enzyme inhibition: from viper to patient

Huang Zhen Hua, 2003:
Angiotensin converting enzyme inhibitor and diabetes mellitus

Dutta, D.; Fischler, M.; McClung, A., 2001:
Angiotensin converting enzyme inhibitor induced hyperkalaemic paralysis

Akishita, M.; Shirakami, G.; Iwai, M.; Wu, L.; Aoki, M.; Zhang, L.; Toba, K.; Horiuchi, M., 2001:
Angiotensin converting enzyme inhibitor restrains inflammation-induced vascular injury in mice

Hill, C.; Logan, A.; Smith, C.; Grønbaek, H.; Flyvbjerg, A., 2001:
Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats

Assadi, F.K.; Wang, H.E.; Lawless, S.; McKay, C.P.; Hopp, L.; Fattori, D., 1999:
Angiotensin converting enzyme inhibitor-induced angioedema: a report of two cases

Awan, A.; Gill, D.G., 2001:
Angiotensin converting enzyme inhibitor-induced angioedema: report of a further case

Vlachogiannakos, J.; Tang, A.K.; Patch, D.; Burroughs, A.K., 2001:
Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease

Mancini, G.B.John, 2001:
Angiotensin converting enzyme inhibitors and restenosis: Let's stop teasing ourselves

Ruschitzka, F.; Noll, G.; Lüscher, T.F., 1999:
Angiotensin converting enzyme inhibitors and vascular protection in hypertension

Van Eickels, M.; Grohe, C.; Loebbert, K.; Stimpel, M.; Vetter, H., 1999:
Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts

Lee, T.G.e; Park, Y.B.om; Park, D.C.oun; Yeum, D.M.n; Kim, I.S.o; Gu, Y.S.k; Park, Y.H.; Kim, S.B.ng, 1998:
Angiotensin converting enzyme inhibitory activity in enzymatic hydrolysates of anchovy muscle protein

Pasha, M.A.Q.dar; Khan, A.P.; Kumar, R.; Grover, S.K.; Ram, R.B.; Norboo, T.; Srivastava, K.K.; Selvamurthy, W.; Brahmachari, S.K., 2001:
Angiotensin converting enzyme insertion allele in relation to high altitude adaptation

Bonnici, Fçois.; Keavney, B.; Collins, R.; Danesh, J., 2002:
Angiotensin converting enzyme insertion or deletion polymorphism and coronary restenosis: meta-analysis of 16 studies

Hassan, A.; Lansbury, A.; Catto, A.J.; Guthrie, A.; Spencer, J.; Craven, C.; Grant, P.J.; Bamford, J.M., 2002:
Angiotensin converting enzyme insertion/deletion genotype is associated with leukoaraiosis in lacunar syndromes

Matsubara, Y.; Hayakawa, T.; Tsuda, T.; Takeshita, E.; Watanabe, G.; Murata, M.; Watanabe, K.; Ikeda, Y., 2000:
Angiotensin converting enzyme insertion/deletion polymorphism is associated with plasma antigen levels of plasminogen activator inhibitor-1 in healthy Japanese population

Marshall, R.P.; Webb, S.; Bellingan, G.J.; Montgomery, H.E.; Chaudhari, B.; McAnulty, R.J.; Humphries, S.E.; Hill, M.R.; Laurent, G.J., 2002:
Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome

de Lannoy, L.M.; Schuijt, M.P.; Saxena, P.R.; Schalekamp, M.A.; Danser, A.H., 2001:
Angiotensin converting enzyme is the main contributor to angiotensin I-II conversion in the interstitium of the isolated perfused rat heart

Ohta, T.; Amaya, K.; Yi, S.; Kitagawa, H.; Kayahara, M.; Ninomiya, I.; Fushida, S.; Fujimura, T.; Nishimura, G-Ichi.; Shimizu, K.; Miwa, K., 2003:
Angiotensin converting enzyme-independent, local angiotensin II-generation in human pancreatic ductal cancer tissues

Cobb, C.S.; Frankling, S.C.; Rankin, J Clifford; Brown, J Anne, 2002:
Angiotensin converting enzyme-like activity in tissues from the river lamprey or lampern, Lampetra fluviatilis, acclimated to freshwater and seawater

Casarini, D.E.; Plavinik, F.L.; Zanella, M.T.; Marson, O.; Krieger, J.E.; Hirata, I.Y.; Stella, R.C.R., 2001:
Angiotensin converting enzymes from human urine of mild hypertensive untreated patients resemble the N-terminal fragment of human angiotensin I-converting enzyme

Costa, R.H.; Casarini, D.E.; Plavnik, F.L.; Marson, O.; Alves, K.B., 2000:
Angiotensin converting-like enzymes from urine of untreated renovascular hypertensive and normal patients: Purification and characterization

Yunge, M.; Petros, A., 2000:
Angiotensin for septic shock unresponsive to noradrenaline

Abdi, R.; Tran, T.B.; Zee, R.; Brenner, B.M.; Milford, E.L., 2001:
Angiotensin gene polymorphism as a determinant of posttransplantation renal dysfunction and hypertension

Blaine, E.H.; Cunningham, J.T.omas; Hasser, E.M.; Dale, W.E.; Li, Q.; Sullivan, M., 1998:
Angiotensin hypertension

Eshima, K.; Hirooka, Y.; Shigematsu, H.; Matsuo, I.; Koike, G.; Sakai, K.; Takeshita, A., 2000:
Angiotensin in the nucleus tractus solitarii contributes to neurogenic hypertension caused by chronic nitric oxide synthase inhibition

Kranzhöfer, R.; Schmidt, J.; Pfeiffer, C.A.; Hagl, S.; Libby, P.; Kübler, W., 1999:
Angiotensin induces inflammatory activation of human vascular smooth muscle cells

Willenbrock, R.; Scheuermann, M.; Thibault, G.; Haass, M.; Höhnel, K.; Bohlender, J.; Luft, F.C.; Dietz, R., 1999:
Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt

Rouleau, J.R.; Simard, D.; Blouin, Aé.; Kingma, J.G., 2002:
Angiotensin inhibition and coronary autoregulation in a canine model of LV hypertrophy

Morimoto, S.; Sigmund, C.D., 2002:
Angiotensin mutant mice: A focus on the brain renin-angiotensin system

Fontes, M.A.; Baltatu, O.; Caligiorne, S.M.; Campagnole-Santos, M.J.; Ganten, D.; Bader, M.; Santos, R.A., 2000:
Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats

Averill, D.B.; Diz, D.I., 2000:
Angiotensin peptides and baroreflex control of sympathetic outflow: Pathways and mechanisms of the medulla oblongata

Blume, A.; Herdegen, T.; Unger, T., 1999:
Angiotensin peptides and inducible transcription factors

Diz, D.I.; Jessup, J.A.; Westwood, B.M.; Bosch, S.M.; Vinsant, S.; Gallagher, P.E.; Averill, D.B., 2002:
Angiotensin peptides as neurotransmitters/neuromodulators in the dorsomedial medulla

Grammatopoulos, T.; Morris, K.; Ferguson, P.; Weyhenmeyer, J., 2002:
Angiotensin protects cortical neurons from hypoxic-induced apoptosis via the angiotensin type 2 receptor

Dagnino Subiabre, A.; Marcelain, K.; Arriagada, C.; Paris, I.; Caviedes, P.; Caviedes, R.; Segura Aguilar, J., 2000:
Angiotensin receptor II is present in dopaminergic cell line of rat substantia nigra and it is down regulated by aminochrome

Kubo, T.; Numakura, H.; Endo, S.; Hagiwara, Y.; Fukumori, R., 2001:
Angiotensin receptor blockade in the anterior hypothalamic area inhibits stress-induced pressor responses in rats

Schwemmer, M.; Sommer, O.; Bassenge, E., 2001:
Angiotensin receptor blocker losartan suppresses platelet activity by interfering with thromboxane signaling

McMurray, J.J., 2001:
Angiotensin receptor blockers for chronic heart failure and acute myocardial infarction

Mackenzie, H.S.; Ziai, F.; Omer, S.A.; Nadim, M.K.; Taal, M.W., 1999:
Angiotensin receptor blockers in chronic renal disease: the promise of a bright clinical future

Greenberg, Barry, H., 2002:
Angiotensin receptor blockers in heart failure: A work in progress

Jong, P.; Demers, C.; Mckelvie, R.S.; Liu, P.P., 2002:
Angiotensin receptor blockers in heart failure: Meta-analysis of randomized controlled trials

Carson, P.; Giles, T.; Higginbotham, M.; Hollenberg, N.; Kannel, W.; Siragy, H.M., 2001:
Angiotensin receptor blockers: Evidence for preserving target organs

Siragy, Helmy, M., 2002:
Angiotensin receptor blockers: How important is selectivity?

Mimran, A.; Ribstein, J., 1999:
Angiotensin receptor blockers: pharmacology and clinical significance

Breno, M.C.istina; Porto, C.S.; Picarelli, Z.P., 2001:
Angiotensin receptor in the heart of Bothrops jararaca snake

Inoue, T.; Mi, Z.; Gillespie, D.G.; Dubey, R.K.; Jackson, E.K., 1999:
Angiotensin receptor subtype 1 mediates angiotensin II enhancement of isoproterenol-induced cyclic AMP production in preglomerular microvascular smooth muscle cells

Helou, C.M.B.; Imbert-Teboul, M.; Doucet, A.; Rajerison, R.; Chollet, C.; Alhenc-Gelas, Fçois.; Marchetti, J., 2003:
Angiotensin receptor subtypes in thin and muscular juxtamedullary efferent arterioles of rat kidney

Kempf, H.; Corvol, P., 2001:
Angiotensin receptor(s) in fowl

Dinh, D.T.; Frauman, A.G.; Johnston, C.I.; Fabiani, M.E., 2001:
Angiotensin receptors: distribution, signalling and function

Nishimura, Hiroko, 2001:
Angiotensin receptors: Evolutionary overview and perspectives

Thomas, W.G.; Mendelsohn, F.A.O., 2003:
Angiotensin receptors: Form and function and distribution

Goodfriend, Theodore, L., 2000:
Angiotensin receptors: History and mysteries

Inagami, T.; Kambayashi, Y.; Ichiki, T.; Tsuzuki, S.; Eguchi, S.; Yamakawa, T., 1999:
Angiotensin receptors: Molecular biology and signalling

Wong, N.L.; Tsui, J.K., 2001:
Angiotensin regulates endothelin-B receptor in rat inner medullary collecting duct

Ma, X.; Chapleau, M.W.; Whiteis, C.A.; Abboud, F.M.; Bielefeldt, K., 2001:
Angiotensin selectively activates a subpopulation of postganglionic sympathetic neurons in mice

Bishopric, N.H., 2002:
Angiotensin signaling and apoptosis in the neonatal heart: necessary evils?

Russell, M.J.; Klemmer, A.M.; Olson, K.R., 2001:
Angiotensin signaling and receptor types in teleost fish

Yoo, K.H.; Thornhill, B.A.; Chevalier, R.L., 2000:
Angiotensin stimulates TGF-beta1 and clusterin in the hydronephrotic neonatal rat kidney

Daido, H.; Zhou, M.Y.; Gomez Sanchez, C.E., 2001:
Angiotensin stimulates the expression of interferon-inducible genes in H295R cells

Nakamura, Y.; Ono, H.; Zhou, X.; Frohlich, E.D., 2001:
Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in Nomega-nitro-L-arginine methyl ester/spontaneously hypertensive rats

Prasad, A.; Halcox, J.P.J.; Waclawiw, M.A.; Quyyumi, A.A., 2001:
Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis

Ambrose, J.; Pribnow, D.G.; Giraud, G.D.; Perkins, K.D.; Muldoon, L.; Greenberg, B.H., 1999 :
Angiotensin type 1 receptor antagonism with irbesartan inhibits ventricular hypertrophy and improves diastolic function in the remodeling post-myocardial infarction ventricle

Ahmad, Z.; Milligan, C.J.; Paton, J.F.R.; Deuchars, J., 2003:
Angiotensin type 1 receptor immunoreactivity in the thoracic spinal cord

Cao, Z.; Bonnet, F.; Candido, R.; Nesteroff, S.P.; Burns, W.C.; Kawachi, H.; Shimizu, F.; Carey, R.M.; De Gasparo, M.; Cooper, M.E., 2002:
Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury

Cao, Z.; Kelly, D.J.; Cox, A.; Casley, D.; Forbes, J.M.; Martinello, P.; Dean, R.; Gilbert, R.E.; Cooper, M.E., 2000:
Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis

Hohenfellner, K.; Hunley, T.E.; Schloemer, C.; Brenner, W.; Yerkes, E.; Zepp, F.; Brock, J.W.IIi; Kon, V., 1999:
Angiotensin type 2 receptor is important in the normal development of the ureter

Siragy, H.M.; de Gasparo, M.; Carey, R.M., 2000:
Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats

Carey, R.M.; Howell, N.L.; Jin, X.H.; Siragy, H.M., 2001:
Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats

Oshima, K.; Miyazaki, Y.; Brock, J.W.IIi; Adams, M.C.; Ichikawa, I.; Pope, J.C.Iv, 2001:
Angiotensin type II receptor expression and ureteral budding

Ueda, S.; Masumori-Maemoto, S.; Wada, A.; Ishii, M.; Brosnihan, K.B.; Umemura, S., 2001:
Angiotensin(1-7) potentiates bradykinin-induced vasodilatation in man

Vaughan, Douglas, E., 2001 :
Angiotensin, fibrinolysis, and vascular homeostasis

Ferrario, Carlos, M., 1998:
Angiotensin-(1-7) and antihypertensive mechanisms

Oliveira, M., A.; Carvalho, M.-Helena, C.; Nigro, D.; Passaglia, R.-De-Cassia-At; Fortes, Z., B., 2002:
Angiotensin-(1-7) and bradykinin interaction in diabetes mellitus: In vivo study

Loot, A., E.; Roks, A., J.M.; Henning, R., H.; Tio, R., A.; Suurmeijer, A., J.H.; Boomsma, F.; Van-Gilst, W., H., 2002:
Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats

Ueda, S.; Masumori-Maemoto, S.; Ashino, K.; Nagahara, T.; Gotoh, E.; Umemura, S.; Ishii, M., 2000:
Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man

Gironacci, M., M.; Coba, M., P.; Pena, C., 1999:
Angiotensin-(1-7) binds at the type 1 angiotensin II receptors in rat renal cortex

Feterik, K.; Smith, L.; Katusic, Z., S., 2000:
Angiotensin-(1-7) causes endothelium-dependent relaxation in canine middle cerebral artery

Zhou-Yuan; Deng-Han-Wu; Li-Yuan-Jian, 2001:
Angiotensin-(1-7) dilates guinea-pig coronary arteries via nitric oxide

Gironacci, M., M.; Rodriguez-Fermepin, M.; Vatta, M.; Fernandez, B., E.; Rubio, M.; Pena, C., 2000:
Angiotensin-(1-7) does not affect norepinephrine neuronal uptake or catabolism in rat hypothalamus and atria

Wilsdorf, T.; Gainer, J.V.; Murphey, L.J.; Vaughan, D.E.; Brown, N.J., 2001:
Angiotensin-(1-7) does not affect vasodilator or TPA responses to bradykinin in human forearm

Clark, M.A.; Diz, D.I.; Tallant, E.A., 2001:
Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells

Zisman, L.S.; Meixell, G.E.; Bristow, M.R.; Canver, C.C., 2003:
Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate

Ferreira, A.J.; Santos, R.A.S.; Almeida, A.P., 2002:
Angiotensin-(1-7) improves the post-ischemic function in isolated perfused rat hearts

Merrill, D.C.; Karoly, M.; Chen, K.; Ferrario, C.M.; Brosnihan, K.Bridget., 2002:
Angiotensin-(1-7) in normal and preeclamptic pregnancy

Santos, J.C.; Jerez, S.; Peral de Bruno, M.; Coviello, A., 2000:
Angiotensin-(1-7) increases osmotic water permeability in isolated toad skin

Zhu, Z.; Zhong, J.; Zhu, S.; Liu, D.; Van Der Giet, M.; Tepel, M., 2002:
Angiotensin-(1-7) inhibits angiotensin II-induced signal transduction

Roks, A.J.; van Geel, P.P.; Pinto, Y.M.; Buikema, H.; Henning, R.H.; de Zeeuw, D.; van Gilst, W.H., 1999:
Angiotensin-(1-7) is a modulator of the human renin-angiotensin system

Caruso-Neves, C.; Lara, L.S.; Rangel, L.B.A.; Grossi, A.L.; Lopes, A.G., 2000:
Angiotensin-(1-7) modulates the ouabain-insensitive Na+-ATPase activity from basolateral membrane of the proximal tubule

Almeida, A.P.; Frábregas, B.C.; Madureira, M.M.; Santos, R.J.; Campagnole-Santos, M.J.; Santos, R.A., 2000:
Angiotensin-(1-7) potentiates the coronary vasodilatatory effect of bradykinin in the isolated rat heart

Gironacci, M.M.; Vatta, M.; Rodriguez-Fermepín, M.; Fernández, B.E.; Peña, C., 2000:
Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus

Clark, M.A.; Tallant, E.Ann.; Tommasi, E.; Bosch, S.; Diz, D.I., 2003:
Angiotensin-(1-7) reduces renal angiotensin II receptors through a cyclooxygenase-dependent mechanism

Strawn, W.B.; Ferrario, C.M.; Tallant, E.A., 1999:
Angiotensin-(1-7) reduces smooth muscle growth after vascular injury

Neves, L., A.A.; Santos, R., A.S.; Khosla, M., C.; Milsted, A., 2000:
Angiotensin-(1-7) regulates the levels of angiotensin II receptor subtype AT1 mRNA differentially in a strain-specific fashion

Gonzales, S.; Noriega, G., O.; Tomaro, M., L.; Pena, C., 2002:
Angiotensin-(1-7) stimulates oxidative stress in rat kidney

Heitsch, H.; Brovkovych, S.; Malinski, T.; Wiemer, G., 2001:
Angiotensin-(1-7)-stimulated nitric oxide and superoxide release from endothelial cells

Buczko, W.; Kucharewicz, I., 2000:
Angiotensin-(1-7). One step forward?

Ferrario, C., M.; Iyer, S., N., 1998:
Angiotensin-(1-7): A bioactive fragment of the renin-angiotensin system

Kucharewicz, I.; Pawlak, R.; Matys, T.; Chabielska, E.; Buczko, W., 2002:
Angiotensin-(1-7): An active member of the renin-angiotensin system

Santos, R., A.S.; Campagnole-Santos, M., J.; Andrade, S., P., 2000 :
Angiotensin-(1-7): An update

Ferreira, A.J.; Santos, R.A.; Almeida, A.P., 2001:
Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion

Maier, L.A.; Raynolds, M.V.; Young, D.A.; Barker, E.A.; Newman, L.S., 1999:
Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease

Cox, R.; Bouzekri, N.; Martin, S.; Southam, L.; Hugill, A.; Golamaully, M.; Cooper, R.; Adeyemo, A.; Soubrier, F.; Ward, R.; Lathrop, G.Mark.; Matsuda, F.; Farrall, M., 2002:
Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides

Woods, D.; Onambele, G.; Woledge, R.; Skelton, D.; Bruce, S.; Humphries, S.E.; Montgomery, H., 2001:
Angiotensin-I converting enzyme genotype-dependent benefit from hormone replacement therapy in isometric muscle strength and bone mineral density

Lee, H.O.; Kim, D.S.o; Do, J.R.ong; Ko, Y.S., 1999:
Angiotensin-I converting enzyme inhibitor activity of algae

Tauzin, Jérôme.; Miclo, L.; Gaillard, J.Luc., 2002:
Angiotensin-I-converting enzyme inhibitory peptides from tryptic hydrolysate of bovine alphaS2-casein

Seguias, L.; Zilleruelo, G.; Strauss, J.; Abitbol, C.; Montane, B., 2001:
Angiotensin-II and endothelin-1 levels in children with renoprival hypertension

Lundergan, W.P.; Ferry, D.; Kobayashi, H.; Snowdowne, K.W., 1999:
Angiotensin-II increases cytoplasmic calcium, cell number and total DNA for human periodontal ligamental cells in vitro

Yoshiji, H.; Kuriyama, S.; Yoshii, J.; Ikenaka, Y.; Noguchi, R.; Yanase, K.; Namisaki, T.; Yamazaki, M.; Tsujinoue, H.; Imazu, H.; Fukui, H., 2003 :
Angiotensin-II induces the tissue inhibitor of metalloproteinases-1 through the protein kinase-C signaling pathway in rat liver fibrosis development

Takekoshi, K.; Ishii, K.; Isobe, K.; Nanmoku, T.; Kawakami, Y.; Nakai, T., 2000:
Angiotensin-II subtype 2 receptor agonist (CGP-42112) inhibits catecholamine biosynthesis in cultured porcine adrenal medullary chromaffin cells

Yoshiji, H.; Kuriyama, S.; Yoshii, J.; Ikenaka, Y.; Noguchi, R.; Nakatani, T.; Tsujinoue, H.; Fukui, H., 2001:
Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats

Anand-Srivastava, M.B.; Palaparti, A., 2003:
Angiotensin-II-induced enhanced expression of Gi proteins is attenuated by losartan in A10 vascular smooth muscle cells: role of AT1 receptors

Salah, A.M.; Dongmo, A.B.; Kamanyi, A.; Bopelet, M.; Wagner, H., 2001:
Angiotensin-conventing enzyme-inhibitory effect by Ruellia praetermissa

Mizuiri, S.; Hemmi, H.; Kumanomidou, H.; Iwamoto, M.; Miyagi, M.; Sakai, K.; Aikawa, A.; Ohara, T.; Yamada, K.; Shimatake, H.; Hasegawa, A., 2001:
Angiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expression

Rupert, J.L.; Devine, D.V.; Monsalve, M.V.; Hochachka, P.W., 1999:
Angiotensin-converting enzyme (ACE) alleles in the Quechua, a high altitude South American native population

Schuermann, M.; Reichel, P.; Mueller-Myhsok, B.; Dieringer, T.; Wurm, K.; Schlaak, M.; Mueller-Quernheim, J.; Schwinger, E., 2001:
Angiotensin-converting enzyme (ACE) gene polymorphisms and familial occurrence of sarcoidosis

Pauls, K.; Fink, L.; Franke, F.E., 1999:
Angiotensin-converting enzyme (CD143) in neoplastic germ cells

Fatini, C.; Gensini, F.; Battaglini, B.; Prisco, D.; Cellai, A.P.; Fedi, S.; Marcucci, R.; Brunelli, T.; Mello, G.; Parretti, E.; Pepe, G.; Abbate, R., 2000:
Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility

Matsubara, M.; Suzuki, M.; Fujiwara, T.; Kikuya, M.; Metoki, H.; Michimata, M.; Araki, T.; Kazama, I.; Satoh, T.; Hashimoto, J.; Hozawa, A.; Ohkubo, T.; Tsuji, I.; Katsuya, T.; Higaki, J.; Ogihara, T.; Satoh, H.; Imai, Y., 2002:
Angiotensin-converting enzyme I/D polymorphism and hypertension: the Ohasama study

Rankinen, T.; Pérusse, L.; Gagnon, J.; Chagnon, Y.C.; Leon, A.S.; Skinner, J.S.; Wilmore, J.H.; Rao, D.C.; Bouchard, C., 2000:
Angiotensin-converting enzyme ID polymorphism and fitness phenotype in the HERITAGE Family Study

Schiavello, T.; Burke, V.; Bogdanova, N.; Jasik, P.; Melsom, S.; Boudville, N.; Robertson, K.; Angelicheva, D.; Dworniczak, B.; Lemmens, M.; Horst, J.; Todorov, V.; Dimitrakov, D.; Sulowicz, W.; Krasniak, A.; Stompor, T.; Beilin, L.; Hallmayer, J.; Kalaydjieva, L.; Thomas, M., 2001:
Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease

Tamaru, N.; Watanabe, K.; Yoshida, M.; Reitz Vick, D.M.; Townsend, L.; Glover, N.J., 2000:
Angiotensin-converting enzyme activity by canine pulmonary microvascular and central pulmonary artery endothelial cells exposed to hypoxia

Schauser, K.H.; Nielsen, A.H.; Dantzer, V.; Poulsen, K., 2001:
Angiotensin-converting enzyme activity in the bovine uteroplacental unit changes in relation to the cycle and pregnancy

Ito, A.; Egashira, K.; Narishige, T.; Muramatsu, K.; Takeshita, A., 2002:
Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus

Alvarez, R.; Reguero, J., R.; Batalla, A.; Iglesias-Cubero, G.; Cortina, A.; Alvarez, V.; Coto, E., 1998:
Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: Association with early coronary disease

Mulatero, P.; Rabbia, F.; di Cella, S.M.; Schiavone, D.; Plazzotta, C.; Pascoe, L.; Veglio, F., 2001:
Angiotensin-converting enzyme and angiotensinogen gene polymorphisms are non-randomly distributed in oral contraceptive-induced hypertension

D.P.dua Mansur, A.; Annicchino Bizzacchi, J.; Favarato, D.; Avakian, S.D.siree; Machado Cesar, L.A.tonio; Franchini Ramires, J.A.tonio, 2000:
Angiotensin-converting enzyme and apolipoprotein B polymorphisms in coronary artery disease

Mansur, A.P.; Annicchino Bizzacchi, J.; Favarato, D.; Avakian, S.D.; Cesar, L.A.M.; Ramires, J.A.F., 2000:
Angiotensin-converting enzyme and apolipoproteins genes polymorphism in coronary artery disease

McElmurray, J.H.; Mukherjee, R.; New, R.B.; Sampson, A.C.; King, M.K.; Hendrick, J.W.; Goldberg, A.; Peterson, T.J.; Hallak, H.; Zile, M.R.; Spinale, F.G.; Zile, M.R., 1999:
Angiotensin-converting enzyme and matrix metalloproteinase inhibition with developing heart failure: comparative effects on left ventricular function and geometry

Fukuhara, M.; Geary, R.L.; Diz, D.I.; Gallagher, P.E.; Wilson, J.A.; Glazier, S.S.; Dean, R.H.; Ferrario, C.M., 2000:
Angiotensin-converting enzyme expression in human carotid artery atherosclerosis

Losito, A.; Selvi, A.; Jeffery, S.; Afzal, A.R.; Parente, B.; Giorgio Cao, P., 2000:
Angiotensin-converting enzyme gene I/D polymorphism and carotid artery disease in renovascular hypertension

Navis, G.; Van Der Kleij, F.G.H.; D.Z.euw, D.; D.J.ng, P.E., 1999:
Angiotensin-converting enzyme gene I/D polymorphism and renal disease

Stefansson, B.; Ricksten, A.; Rymo, L.; Aurell, M.; Herlitz, H., 2000:
Angiotensin-converting enzyme gene I/D polymorphism in malignant hypertension

Paterna, S.; Di Pasquale, P.; D'Angelo, A.; Seidita, G.; Tuttolomondo, A.; Cardinale, A.; Maniscalchi, T.; Follone, G.; Giubilato, A.; Tarantello, M.; Licata, G., 2000:
Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura

A.E.sa, A.; Haider, M.Z.; Srivastva, B.S., 2000:
Angiotensin-converting enzyme gene insertion/deletion polymorphism and renal damage in childhood uropathies

Haider, M.Z.; Devarajan, L.V.; Al-Essa, M.; Kumar, H., 2002:
Angiotensin-converting enzyme gene insertion/deletion polymorphism in Kuwaiti children with retinopathy of prematurity

Lee, Y.J.unn; Tsai, J.C.R., 2001:
Angiotensin-converting enzyme gene insertion/deletion, not bradykinin B2 receptor -58T/C gene polymorphism, associated with angiotensin-converting enzyme inhibitor-related cough in Chinese female patients with non-insulin-dependent diabetes mellitus

Holla, L.; Vasku, A.; Soucek, M.; Krahulcova, E.; Hajek, D.; Znojil, V., 1998:
Angiotensin-converting enzyme gene polymorphism and blood groups of the AB0 system in leukaemias compared with controls and hypertensives

Sayed-Tabatabaei, F.A.; Houwing-Duistermaat, J.J.; van Duijn, C.M.; Witteman, J.C.M., 2003:
Angiotensin-converting enzyme gene polymorphism and carotid artery wall thickness: a meta-analysis

Hung, J.; McQuillan, B.M.; Nidorf, M.; Thompson, P.L.; Beilby, J.P., 1999:
Angiotensin-converting enzyme gene polymorphism and carotid wall thickening in a community population

Araz, M.; Yilmaz, N.; Gungor, K.; Okan, V.; Kepekci, Y.; Aynacioglu, A.S.kru, 2001:
Angiotensin-converting enzyme gene polymorphism and microvascular complications in Turkish type 2 diabetic patients

Maliarik, M.J.; Rybicki, B.A.; Malvitz, E.; Sheffer, R.G.; Major, M.; Popovich, J.; Iannuzzi, M.C., 1998:
Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis

Uhm, W.S.; Lee, H.S.; Chung, Y.H.; Kim, T.H.; Bae, S.C.; Joo, K.B.; Kim, T.Y.; Yoo, D.H., 2002:
Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE

Okuno, S.; Utsugi, T.; Ohno, T.; Ohyama, Y.; Uchiyama, T.; Tomono, S.; Kurabayashi, M., 2003:
Angiotensin-converting enzyme gene polymorphism as a potent risk factor for developing microalbuminuria in Japanese patients with type 2 diabetes mellitus: a 9-year follow-up study

Eichner, J.E.; Christiansen, V.J.; Moore, W.E.; Dunn, S.T.rence; Schechter, E., 2001:
Angiotensin-converting enzyme gene polymorphism in a cohort of coronary angiography patients

Prkacin, I.; Novak, B.; Sertić, J.; Mrzljak, A., 2001:
Angiotensin-converting enzyme gene polymorphism in patients with systemic lupus

Planck, A.; Eklund, A.; Yamaguchi, E.; Grunewald, J., 2002:
Angiotensin-converting enzyme gene polymorphism in relation to HLA-DR in sarcoidosis

Cao Wen; Ling Shusen; Zhang Qigao; Chen Yali, 1999:
Angiotensin-converting enzyme gene polymorphism in untreated essential hypertension and response to angiotensin converting enzyme inhibitors

Dellgren, G.; Eriksson, M.J.; Blange, I.; Brodin, L.A.e; Radegran, K.; Sylven, C., 1999:
Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis

Palmer, B.R.; Pilbrow, A.P.; Yandle, T.G.; Frampton, C.M.; Richards, A.M.rk; Nicholls, M.G.ry; Cameron, V.A., 2003:
Angiotensin-converting enzyme gene polymorphism interacts with left ventricular ejection fraction and brain natriuretic peptide levels to predict mortality after myocardial infarction

Fernández-Solà, J.; Nicolás, J.María.; Oriola, J.; Sacanella, E.; Estruch, Rón.; Rubin, E.; Urbano-Márquez, A., 2002:
Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy

Chai, S.; Sohn, D.R.ul, 1998:
Angiotensin-converting enzyme gene polymorphism is not associated with myocardial infarction in Koreans

Pola, E.; Gaetani, E.; Pola, R.; Papaleo, P.; Flex, A.; Aloi, F.; D.S.ntis, V.; Santoliquido, A.; Pola, P., 2002:
Angiotensin-converting enzyme gene polymorphism may influence blood loss in a geriatric population undergoing total hip arthroplasty

Martin, J.K.; Hayney, M.S., 1999:
Angiotensin-converting enzyme gene polymorphism: is there a link to nephropathy in patients with type 1 diabetes?

Folland, J.; Leach, B.; Little, T.; Hawker, K.; Myerson, S.; Montgomery, H.; Jones, D., 2000:
Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload

Santos, N.M.Delos.; Ault, B.H.; Gharavi, A.G.; Kritchevsky, S.B.; Quasney, M.W.; Jackson, E.C.; Fisher, K.A.; Woodford, S.Y.; Mitchell, B.L.; Gaber, L.W.; Arheart, K.L.; Wyatt, R.J., 2002:
Angiotensin-converting enzyme genotype and outcome in pediatric IgA nephropathy

Hu, J.; Miyatake, F.; Aizu, Y.; Nakagawa, H.; Nakamura, S.; Tamaoka, A.; Takahash, R.; Urakami, K.; Shoji, M., 1999:
Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population

Abraham, M.Roselle.; Olson, L.J.; Joyner, M.J.; Turner, S.T.; Beck, K.C.; Johnson, B.D., 2002:
Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure

Metzger, R.; Bohle, R.M.; Pauls, K.; Eichner, G.; Alhenc-Gelas, F.; Danilov, S.M.; Franke, F.E., 1999:
Angiotensin-converting enzyme in non-neoplastic kidney diseases

Mervaala, E.; Dehmel, B.; Gross, V.; Lippoldt, A.; Bohlender, J.; Milia, A.F.; Ganten, D.; Luft, F.C., 1999:
Angiotensin-converting enzyme inhibition and AT1 receptor blockade modify the pressure-natriuresis relationship by additive mechanisms in rats with human renin and angiotensinogen genes

van Kats, J.P.; Duncker, D.J.; Haitsma, D.B.; Schuijt, M.P.; Niebuur, R.; Stubenitsky, R.; Boomsma, F.; Schalekamp, M.A.; Verdouw, P.D.; Danser, A.H., 2000:
Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II

Cashin Hemphill, L.; Holmvang, G.; Chan, R.C.; Pitt, B.; Dinsmore, R.E.; Lees, R.S., 1999:
Angiotensin-converting enzyme inhibition as antiatherosclerotic therapy: No answer yet

Zaman, A.K.; Fujii, S.; Sawa, H.; Goto, D.; Ishimori, N.; Watano, K.; Kaneko, T.; Furumoto, T.; Sugawara, T.; Sakuma, I.; Kitabatake, A.; Sobel, B.E., 2001:
Angiotensin-converting enzyme inhibition attenuates hypofibrinolysis and reduces cardiac perivascular fibrosis in genetically obese diabetic mice

Jonsson, J.R.; Clouston, A.D.; Ando, Y.; Kelemen, L.I.; Horn, M.J.; Adamson, M.D.; Purdie, D.M.; Powell, E.E., 2001:
Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis

Lods, Nège.; Ferrari, P.; Frey, F.J.; Kappeler, A.; Berthier, C.; Vogt, B.; Marti, H-Peter., 2003:
Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis

Matsumoto, T.; Minai, K.; Horie, H.; Ohira, N.; Takashima, H.; Tarutani, Y.; Yasuda, Y.; Ozawa, T.; Matsuo, S.; Kinoshita, M.; Horie, M., 2003:
Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients

Peters, H.; Rückert, M.; Gaedeke, J.; Liefeldt, L.; Ketteler, M.; Sharma, A.M.; Neumayer, H-H., 2003:
Angiotensin-converting enzyme inhibition but not beta-adrenergic blockade limits transforming growth factor-beta overexpression in acute normotensive anti-thy1 glomerulonephritis

Ramalho, F.S.; Ramalho, L.N.; Castro-E-Silva Júnior, O.; Zucoloto, S.; Corrêa, F.M., 2001:
Angiotensin-converting enzyme inhibition by lisinopril enhances liver regeneration in rats

Jaberansari, M.T.; Baxter, G.F.; Muller, C.A.; Latouf, S.E.; Roth, E.; Opie, L.H.; Yellon, D.M., 2001:
Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium

Guazzi, M.; Melzi, G.; Marenzi, G.C.; Agostoni, P., 1999:
Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction

Pradhan, R.; Fong, D.; March, C.; Jack, R.; Rezapour, G.; Norris, K.; Davidson, M.B., 2002:
Angiotensin-converting enzyme inhibition for the treatment of moderate to severe diabetic retinopathy in normotensive Type 2 diabetic patients: A pilot study

Yamauchi, S.; Takeishi, Y.; Minamihaba, O.; Arimoto, T.; Hirono, O.; Takahashi, H.; Miyamoto, T.; Nitobe, J.; Nozaki, N.; Tachibana, H.; Watanabe, T.; Fukui, A.; Kubota, I., 2003:
Angiotensin-converting enzyme inhibition improves cardiac fatty acid metabolism in patients with congestive heart failure

Takeshita, S.; Tomiyama, H.; Yokoyama, N.; Kawamura, Y.; Furukawa, T.; Ishigai, Y.; Shibano, T.; Isshiki, T.; Sato, T., 2001:
Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats

Chalon, S.; Moreno, H.; Hoffman, B.B.; Blaschke, T.F., 1999:
Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers

Dunstan, H.J.; Briscoe, T.A.; Bertram, J.F.; Johnston, C.I.; Black, M.J., 2003:
Angiotensin-converting enzyme inhibition in adult hypertensive rats: A stereological study of renal filtration surface area

Pretorius, M.; Rosenbaum, D.; Vaughan, D.E.; Brown, N.J., 2003:
Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin

Glicklich, D.; Burris, L.; Urban, A.; Tellis, V.; Greenstein, S.; Schechner, R.; Devarajan, P.; Croizat, H., 2001:
Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis

Glezerman, I.; Patel, H.; Glicklich, D.; Croizat, H.; Devarajan, P., 2003:
Angiotensin-converting enzyme inhibition induces death receptor apoptotic pathways in erythroid precursors following renal transplantation

Kilhovd, B.K.; Hjerkinn, E.; Seljeflot, I.; Reikvam, A., 2003:
Angiotensin-converting enzyme inhibition influences serum levels of advanced glycation end products in patients with coronary artery disease: Results from a HOPE substudy

Kennon, S.; Barakat, K.; Hitman, G.A.; Price, C.P.; Mills, P.G.; Ranjadayalan, K.; Cooper, J.; Clark, H.; Timmis, A.D., 2001:
Angiotensin-converting enzyme inhibition is associated with reduced troponin release in non-ST-elevation acute coronary syndromes

Campbell, D.J.; Duncan, A.M.; Kladis, A., 1999:
Angiotensin-converting enzyme inhibition modifies angiotensin but not kinin peptide levels in human atrial tissue

Siragy, H.M.; de Gasparo, M.; El-Kersh, M.; Carey, R.M., 2001:
Angiotensin-converting enzyme inhibition potentiates angiotensin II type 1 receptor effects on renal bradykinin and cGMP

Benigni, A.; Gagliardini, E.; Remuzzi, A.; Corna, D.; Remuzzi, G., 2001:
Angiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist

Soejima, H.; Ogawa, H.; Yasue, H.; Kaikita, K.; Takazoe, K.; Nishiyama, K.; Misumi, K.; Miyamoto, S.; Yoshimura, M.; Kugiyama, K.; Nakamura, S.; Tsuji, I., 1999:
Angiotensin-converting enzyme inhibition reduces monocyte chemoattractant protein-1 and tissue factor levels in patients with myocardial infarction

Yasuda, S.; Goto, Y.; Sumida, H.; Noguchi, T.; Baba, T.; Miyazaki, S.; Nonogi, H., 1999:
Angiotensin-converting enzyme inhibition restores hepatocyte growth factor production in patients with congestive heart failure

Hosomi, N.; Mizushige, K.; Ohyama, H.; Takahashi, T.; Kitadai, M.; Hatanaka, Y.; Matsuo, H.; Kohno, M.; Koziol, J.A., 2001:
Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non-insulin-dependent diabetes mellitus

Schmidt, T.D.; McGrath, K.M., 2002:
Angiotensin-converting enzyme inhibitor angioedema of the intestine: a case report and review of the literature

Kuno, A.; Yamada, T.; Masuda, K.; Ogawa, K.; Sogawa, M.; Nakamura, S.; Nakazawa, T.; Ohara, H.; Nomura, T.; Joh, T.; Shirai, T.; Itoh, M., 2003:
Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats

Odaka, C.; Mizuochi, T., 2000:
Angiotensin-converting enzyme inhibitor captopril prevents activation-induced apoptosis by interfering with T cell activation signals

Roe, C.M.; Motheral, B.R.; Teitelbaum, F.; Rich, M.W., 1999:
Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure

Chen, Y.T.; Wang, Y.; Radford, M.J.; Krumholz, H.M., 2001:
Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure

Nomoto, T.; Nishina, T.; Miwa, S.; Tsuneyoshi, H.; Maruyama, I.; Nishimura, K.; Komeda, M., 2002:
Angiotensin-converting enzyme inhibitor helps prevent late remodeling after left ventricular aneurysm repair in rats

Carvalho, D.S.; Villaca, V.; Brenelli, S.L.; Carvalho, C.R.O.; Saad, M.J.A., 1998:
Angiotensin-converting enzyme inhibitor increases insulin-induced pp185 phosphorylation in liver and muscle of obese rats

Watanabe, T.; Hashimoto, M.; Wada, M.; Imoto, T.; Miyoshi, M.; Sadamitsu, D.; Maekawa, T., 2000:
Angiotensin-converting enzyme inhibitor inhibits dehydration-enhanced fever induced by endotoxin in rats

Kanno, S.; Wu, Y.J.; Lee, P.C.; Billiar, T.R.; Ho, C., 2001:
Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats

Goto, K.; Fujii, K.; Onaka, U.; Abe, I.; Fujishima, M., 2000:
Angiotensin-converting enzyme inhibitor prevents age-related endothelial dysfunction

Katoh, M.; Egashira, K.; Mitsui, T.; Chishima, S.; Takeshita, A.; Narita, H., 2000:
Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis

Benzing, T.; Fleming, I.; Blaukat, A.; Müller-Esterl, W.; Busse, R., 1999:
Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells

Coirault, C.; Hagège, A.; Chemla, D.; Fratacci, M.D.; Guérot, C.; Lecarpentier, Y., 2001:
Angiotensin-converting enzyme inhibitor therapy improves respiratory muscle strength in patients with heart failure

Morawietz, H.; Goettsch, W.; Szibor, M.; Barton, M.; Shaw, S.; Hakim, K.; Zerkowski, H.R.; Holtz, J., 2002:
Angiotensin-converting enzyme inhibitor therapy prevents upregulation of endothelin-converting enzyme-1 in failing human myocardium

Philbin, E.F.; Santella, R.N.; Rocco, T.A., 1999:
Angiotensin-converting enzyme inhibitor use in older patients with heart failure and renal dysfunction

Bakris, G.L.; Weir, M.R., 2000:
Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?

Chiu, A.G.; Newkirk, K.A.; Davidson, B.J.; Burningham, A.R.; Krowiak, E.J.; Deeb, Z.E., 2001:
Angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter review and an algorithm for airway management

Rosenberg, E.I.; Mishra, G.; Abdelmalek, M.F., 2003:
Angiotensin-converting enzyme inhibitor-induced isolated visceral angioedema in a liver transplant recipient

Muchnick, J.S.; Mehta, J.L., 1999:
Angiotensin-converting enzyme inhibitor-induced pancreatitis

Izzedine, H.; Fardet, L.; Launay-Vacher, V.; Dorent, R.; Petitclerc, T.; Deray, G., 2002:
Angiotensin-converting enzyme inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone: case report and review of the literature

Herkner, H.; Havel, C.; Gamper, G.; Bur, A.; Kletzmeyr, J.; Laggner, A.N., 2001:
Angiotensin-converting enzyme inhibitor-related angioedema necessitating endotracheal intubation

Qadri, F.; Arens, T.; Schwartz, E.C.; Häuser, W.; Dominiak, P., 2001:
Angiotensin-converting enzyme inhibitors and AT1-receptor antagonist restore nitric oxide synthase (NOS) activity and neuronal NOS expression in the adrenal glands of spontaneously hypertensive rats

Kitakaze, M.; Asanuma, H.; Funaya, H.; Node, K.; Takashima, S.; Sanada, S.; Asakura, M.; Ogita, H.; Kim, J.; Hori, M., 2002:
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin

Palmer, B.F., 2003:
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises

Maschio, G.; Alberti, D.; Locatelli, F.; Mann, J.F.E.; Motolese, M.; Ponticelli, C.; Ritz, E.; Janin, G.; Zucchelli, P., 1999:
Angiotensin-converting enzyme inhibitors and kidney protection: The APIRI trial

Jafar, T.H.; Schmid, C.H.; Landa, M.; Giatras, I.; Toto, R.; Remuzzi, G.; Maschio, G.; Brenner, B.M.; Kamper, A.; Zucchelli, P.; Becker, G.; Himmelmann, A.; Bannister, K.; Landais, P.; Shahinfar, S.; de Jong, P.E.; de Zeeuw, D.; Lau, J.; Levey, A.S., 2001:
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

Friis, S.; Sorensen, H.T.; Mellemkjaer, L.; Mclaughlin, J.K.; Nielsen, G.L.; Blot, W.J.; Olsen, J.H., 2001:
Angiotensin-converting enzyme inhibitors and the risk of cancer: A population-based cohort study in Denmark

Hamilton, R.A.; Kane, M.P.; Demers, J., 2003:
Angiotensin-converting enzyme inhibitors and type 2 diabetic nephropathy: A meta-analysis

Napoleone, E.; Di Santo, A.; Camera, M.; Tremoli, E.; Lorenzet, R., 2000:
Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes

Hankey, G.J., 2003:
Angiotensin-converting enzyme inhibitors for stroke prevention: is there HOPE for PROGRESS After LIFE?

Nikolaidis, L.A.; Doverspike, A.; Huerbin, R.; Hentosz, T.; Shannon, R.P., 2002:
Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism

Hechter, S.J.; Fredriksen, P.M.rten; Liu, P.; Veldtman, G.; Merchant, N.; Freeman, M.; Therrien, J.; Benson, L.; Siu, S.; Webb, G., 2001:
Angiotensin-converting enzyme inhibitors in adults after the mustard procedure

Thilly, N.; Briancon, S.; Juilliere, Y.; Dufay, E.; Zannad, F., 2002:
Angiotensin-converting enzyme inhibitors in congestive heart failure: Practice versus guidelines

Alyavi, A.L.; Nikitin, N.P., 1998:
Angiotensin-converting enzyme inhibitors in the treatment of chronic heart failure

Coppo, R., 1999:
Angiotensin-converting enzyme inhibitors in young patients with IgA nephropathy: effects against deterioration of renal function. A Biomedicine and Health Research Concerted Action

Arai, T.; Yasuda, Y.; Takaya, T.; Toshima, S.; Kashiki, Y.; Shibayama, M.; Yoshimi, N.; Fujiwara, H., 2001:
Angiotensin-converting enzyme inhibitors, angiotensin-II receptor antagonists, and pneumonia in elderly hypertensive patients with stroke

Meier, C.R.; Derby, L.E.; Jick, S.S.; Jick, H., 2000:
Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer

Lombardi, W.L.; Litwin, S.E., 1999:
Angiotensin-converting enzyme inhibitors: congestive heart failure and beyond

Frossard, P.M.; Bokhari, A.M.; Elshahat, Y.I.; Lestringant, G.G.; John, A.M.; Hill, S.H.; Abdulle, A.M.; Obineche, E.N., 1998:
Angiotensin-converting enzyme insertion or deletion dimorphism in predisposition to cardiovascular diseases amongst United Arab Emirates nationals

Morgan, L.; Foster, F.; Hayman, R.; Crawshaw, S.; Baker, P.N.; Broughton Pipkin, F.; Kalsheker, N., 1999:
Angiotensin-converting enzyme insertion-deletion polymorphism in normotensive and pre-eclamptic pregnancies

Okura, Y.; Hayashi, K.; Shingu, T.; Kuga, Y.; Nomura, S.; Kajiyama, G.; Nakashima, Y.; Saku, K., 2003:
Angiotensin-converting enzyme insertion/deletion genotype is associated with the activities of plasma coagulation factor VII and X independent of triglyceride metabolism

Ito, H.; Tsukui, S.; Kanda, T.; Utsugi, T.; Ohno, T.; Kurabayashi, M., 2002:
Angiotensin-converting enzyme insertion/deletion polymorphism and polyneuropathy in type 2 diabetes without macroalbuminuria

Syrjänen, J.; Huang, X.H.; Mustonen, J.; Koivula, T.; Lehtimäki, T.; Pasternack, A., 2000:
Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy

Ferrari, M.; Mudra, H.; Grip, L.; Voudris, V.; Schächinger, V.; de Jaegere, P.; Rieber, J.; Hausmann, D.; Rothman, M.; Koschyk, D.H.; Figulla, H.R., 2002:
Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation

Murphey, L.J.; Gainer, J.V.; Vaughan, D.E.; Brown, N.J., 2000:
Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin

Largo, R.; Gómez-Garre, D.; Soto, K.; Marrón, B.; Blanco, J.; Gazapo, R.M.; Plaza, J.J.; Egido, J., 1999:
Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria

Dzimiri, N.; Basco, C.; Moorji, A.; Meyer, B.F., 2000:
Angiotensin-converting enzyme polymorphism and the risk of coronary heart disease in the Saudi male population

Brown, R.E., 2000:
Angiotensin-converting enzyme, transforming growth factor beta(1), and interleukin 11 in the osteolytic lesions of Langerhans cell histiocytosis

Takahashi, T.; Ueno, H.; Yasumoto, K.; Kagitani, S.; Tomoda, F.; Inoue, H.; Takata, M., 2003:
Angiotensin-converting enzyme-gene polymorphism is associated with collagen I synthesis and QT dispersion in essential hypertension

Maruyama, R.; Hatta, E.; Yasuda, K.; Smith, N.C.; Levi, R., 2000:
Angiotensin-converting enzyme-independent angiotensin formation in a human model of myocardial ischemia: modulation of norepinephrine release by angiotensin type 1 and angiotensin type 2 receptors

Padmanabhan, N.; Jardine, A.G.; McGrath, J.C.; Connell, J.M., 1999:
Angiotensin-converting enzyme-independent contraction to angiotensin I in human resistance arteries

Goetz, R.M.; Holtz, J., 2000:
Angiotensin-converting enzyme: induction by hypertension-induced vessel distension

Montgomery, H.; Clarkson, P.; Barnard, M.; Bell, J.; Brynes, A.; Dollery, C.; Hajnal, J.; Hemingway, H.; Mercer, D.; Jarman, P.; Marshall, R.; Prasad, K.; Rayson, M.; Saeed, N.; Talmud, P.; Thomas, L.; Jubb, M.; World, M.; Humphries, S., 1999:
Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training

Plata, R.; Cornejo, A.; Arratia, C.; Anabaya, A.; Perna, A.; Dimitrov, B.D.; Remuzzi, G.; Ruggenenti, P., 2002:
Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: A prospective randomised trial

Borgia, M.C.; Celestini, A.; Caravella, P.; Catalano, C., 2001:
Angiotensin-converting-enzyme inhibitor administration must be monitored for serum amylase and lipase in order to prevent an acute pancreatitis: a case report

Watanabe, T.; Miyoshi, M.; Nagata, K.; Imoto, T., 2003:
Angiotensin-converting-enzyme inhibitor, lisinopril, reduces lipopolysaccharide-induced expression of splenic interleukin-6 mRNA in dehydrated rats

Ziogas, J.; Vessey, K., 2001:
Angiotensin-induced enhancement of excitatory junction potentials evoked by periarteriolar nerve stimulation and vasoconstriction in rat mesenteric arteries are both mediated by the angiotensin AT1 receptor

Wilensky, Robert, L., 2003:
Angiotensin-receptor blockers: Revival of the systemic prevention of restenosis?

Prieto, I.; Hermoso, F.; D.G.sparo, M.; Vargas, F.; Alba, F.; Segarra, A.B.; Banegas, I.; Ramirez, M., 2003:
Angiotensinase activities in the kidney of renovascular hypertensive rats

Tanaka, J.; Hayashi, Y.; Nomura, S.; Miyakubo, H.; Okumura, T.; Sakamaki, K., 2001:
Angiotensinergic and noradrenergic mechanisms in the hypothalamic paraventricular nucleus participate in the drinking response induced by activation of the subfornical organ in rats

Danser, A.H.Jan; Derkx, F., H.M.; Hense, H.-Werner; Jeunemaitre, X.; Riegger, G., A.J.; Schunkert, H., 1998:
Angiotensinogen (M235T) and angiotensin-converting enzyme (I/D) polymorphisms in association with plasma renin and prorenin levels

Zychma, M.J.; Zukowska-Szczechowska, E.; Lacka, B.I.; Grzeszczak, W., 2000:
Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes

Hertwig, S.; Völzke, H.; Robinson, D.M.; Motz, W.; Rettig, R., 2002:
Angiotensinogen M235T gene polymorphism and recurrent restenosis after repeated percutaneous transluminal coronary angiography

Prasad, G.V.Ramesh.; Pinnaduwage, D.; Parkes, R.K.; Midgley, J.; Balfe, J.Williamson.; Hegele, R.A.; Bull, S.B.; Cole, E.H.; Logan, A.G., 2003:
Angiotensinogen M235T genotype predicts progression in chronic renal allograft dysfunction

McCole, S.D.; Brown, M.D.; Moore, G.E.; Ferrell, R.E.; Wilund, K.R.; Huberty, A.; Douglass, L.W.; Hagberg, J.M., 2002:
Angiotensinogen M235T polymorphism associates with exercise hemodynamics in postmenopausal women

Winkelmann, B.R.; Russ, A.P.; Nauck, M.; Klein, B.; Boehm, B.O.; Maier, V.; Zotz, R.; Matheis, G.; Wolf, A.; Wieland, H.; Gross, W.; Galton, D.J.; Maerz, W., 1999:
Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease

Gardemann, A.; Stricker, J.; Humme, J.; Nguyen, Q.D.; Katz, N.; Philipp, M.; Tillmanns, H.; Hehrlein, F.W.lhelm; Haberbosch, W., 1999:
Angiotensinogen T174M and M235T gene polymorphisms are associated with the extent of coronary atherosclerosis

Iso, H.; Harada, S.; Shimamoto, T.; Sato, S.; Kitamura, A.; Sankai, T.; Tanigawa, T.; Iida, M.; Komachi, Y., 2000:
Angiotensinogen T174M and M235T variants, sodium intake and hypertension among non-drinking, lean Japanese men and women

Morgan, T.; Craven, C.; Lalouel, J.M.rc; Ward, K., 1999:
Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua

Lee, K-Beck.; Kim, U.Kyung., 2003:
Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: effect on hypertension and ESRD

Meira Lima, I.V.; Pereira, A.C.; Mota, G.F.A.; Krieger, J.E.; Vallada, H., 2000:
Angiotensinogen and angiotensin converting enzyme gene polymorphisms and the risk of bipolar affective disorder in humans

Bashford, M.T.; Hefler, L.A.; Vertrees, T.W.; Roa, B.B.; Gregg, A.R., 2001:
Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia

Célérier, Jérôme.; Cruz, A.; Lamandé, Nël.; Gasc, J-Marie.; Corvol, P., 2002:
Angiotensinogen and its cleaved derivatives inhibit angiogenesis

Bohlender, J.; Ménard, J.; Ganten, D.; Luft, F.C., 2000:
Angiotensinogen concentrations and renin clearance : implications for blood pressure regulation

Leung, P.S.ng; Wong, T.P.; Sernia, C., 1999:
Angiotensinogen expression by rat epididymis: Evidence for an intrinsic, angiotensin-generating system

Karjalainen, J.; Kujala, U.M.; Stolt, A.; Mantysaari, M.; Viitasalo, M.; Kainulainen, K.; Kontula, K., 1999:
Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes

Procopciuc, L.; Jebeleanu, G.; Surcel, I.; Puscas, M., 2002:
Angiotensinogen gene M235T variant and pre-eclampsia in Romanian pregnant women

Kato, N.; Sugiyama, T.; Morita, H.; Kurihara, H.; Yamori, Y.; Yazaki, Y., 1999:
Angiotensinogen gene and essential hypertension in the Japanese: extensive association study and meta-analysis on six reported studies

Hilgers, K.F.; Delles, C.; Veelken, R.; Schmieder, R.E., 2001:
Angiotensinogen gene core promoter variants and non-modulating hypertension

Ray, S.; Sherman, C.T.; Lu, M.; Brasier, A.R., 2002:
Angiotensinogen gene expression is dependent on signal transducer and activator of transcription 3-mediated p300/cAMP response element binding protein-binding protein coactivator recruitment and histone acetyltransferase activity

Tsai, C-Ti.; Fallin, D.; Chiang, F-Tien.; Hwang, J-Jen.; Lai, L-Ping.; Hsu, K-Lih.; Tseng, C-Den.; Liau, C-Suong.; Tseng, Y-Zu., 2003:
Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele

Sun, Z.; Cade, R.; Zhang, Z.; Alouidor, J.; Van, H., 2003:
Angiotensinogen gene knockout delays and attenuates cold-induced hypertension

Chistyakov, D.A.; Turakulov, R.I.; Kondrat'ev, Y.Y.; Shestakova, M.V.; Nosikov, V.V.; Dedov, I.I.; Debabov, V.G., 1999:
Angiotensinogen gene polymorphism and genetic predisposition to diabetic nephropathy in type I diabetes mellitus

Jain, S.; Tang, X.; Narayanan, C.S.; Agarwal, Y.; Peterson, S.M.; Brown, C.D.; Ott, J.; Kumar, A., 2002:
Angiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans

Ishigami, T.; Tamura, K.; Fujita, T.; Kobayashi, I.; Hibi, K.; Kihara, M.; Toya, Y.; Ochiai, H.; Umemura, S., 1999:
Angiotensinogen gene polymorphism near transcription start site and blood pressure: role of a T-to-C transition at intron I

Sethi, A.Akhtar.; Nordestgaard, Børge.Grønne.; Tybjaerg-Hansen, A., 2003:
Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis

Niu, T.; Yang, J.; Wang, B.; Chen, W.; Wang, Z.; Laird, N.; Wei, E.; Fang, Z.; Lindpaintner, K.; Rogus, J.J.; Xu, X., 1999:
Angiotensinogen gene polymorphisms M235T/T174M: no excess transmission to hypertensive Chinese

Schmidt, H.; Fazekas, F.; Kostner, G.M.; van Duijn, C.M.; Schmidt, R., 2001:
Angiotensinogen gene promoter haplotype and microangiopathy-related cerebral damage: results of the Austrian Stroke Prevention Study

Tiago, A.D.; Samani, N.J.; Candy, G.P.; Brooksbank, R.; Libhaber, E.N.; Sareli, P.; Woodiwiss, A.J.; Norton, G.R., 2002:
Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension

Narita, I.; Goto, S.; Saito, N.; Song, J.; Omori, K.; Kondo, D.; Sakatsume, M.; Gejyo, F., 2003:
Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy

Nishii, T.; Moriguchi, A.; Morishita, R.; Yamada, K.; Nakamura, S.; Tomita, N.; Kaneda, Y.; Fukamizu, A.; Mikami, H.; Higaki, J.; Ogihara, T., 1999:
Angiotensinogen gene-activating elements regulate blood pressure in the brain

Hopkins, P.N.; Hunt, S.C.; Jeunemaitre, X.; Smith, B.; Solorio, D.; Fisher, N.D.L.; Hollenberg, N.K.; Williams, G.H., 2002:
Angiotensinogen genotype affects renal and adrenal responses to angiotensin II in essential hypertension

Davis, D.; Liyou, N.; Lockwood, D.; Johnson, A., 2002:
Angiotensinogen genotype, plasma protein and mRNA concentration in isolated systolic hypertension

Lalouel, J.M.; Rohrwasser, A.; Terreros, D.; Morgan, T.; Ward, K., 2001:
Angiotensinogen in essential hypertension: from genetics to nephrology

Regoli, M.; Bendayan, M.; Fonzi, L.; Sernia, C.; Bertelli, E., 2003:
Angiotensinogen localization and secretion in the rat pancreas

Sethi, A.A.; Tybjaerg-Hansen, A.; Grønholdt, M.L.; Steffensen, R.; Schnohr, P.; Nordestgaard, B.G., 2001:
Angiotensinogen mutations and risk for ischemic heart disease, myocardial infarction, and ischemic cerebrovascular disease. Six case-control studies from the Copenhagen City Heart Study

Schmidt, R.; Schmidt, H.; Fazekas, F.; Launer, L.J.; Niederkorn, K.; Kapeller, P.; Lechner, A.; Kostner, G.M., 2001:
Angiotensinogen polymorphism M235T, carotid atherosclerosis, and small-vessel disease-related cerebral abnormalities

Sethi, A.A.; Nordestgaard, B.G.; Agerholm-Larsen, B.; Frandsen, E.; Jensen, G.; Tybjaerg-Hansen, A., 2001:
Angiotensinogen polymorphisms and elevated blood pressure in the general population: the Copenhagen City Heart Study

Sethi, A.A.; Nordestgaard, Børge.G.; Grønholdt, M-Louise.M.; Steffensen, R.; Jensen, G.; Tybjaerg-Hansen, A., 2003:
Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease

Ochedalska, A.L.chowicz; Rebas, E.; Kunert Radek, J.; Fournie Zaluski, M.C.aude; Pawlikowski, M., 2002:
Angiotensins II and IV stimulate the activity of tyrosine kinases in estrogen-induced rat pituitary tumors

Sim, M.K.; Qui, X.S., 2003:
Angiotensins in plasma of hypertensive rats and human

Malicki, D.M.; Suh, Y.K.; Fuller, G.N.; Shin, S.S., 1999:
Angiotropic (intravascular) large cell lymphoma of T-cell phenotype presenting as acute appendicitis in a patient with acquired immunodeficiency syndrome

Watabe, R.; Shibata, K.; Hirase, N.; Kodera, T.; Muta, K.; Nishimura, J.; Nawata, H., 2000:
Angiotropic B-cell lymphoma with hemophagocytic syndrome associated with syndrome of inappropriate secretion of antidiuretic hormone

Deusch, E.; Mayr, A.; Hobisch Hagen, P.; Fend, F.; Mutz, N.; Bangerl, I.; Hasibeder, W., 1999:
Angiotropic large B-cell lymphoma misdiagnosed as urosepsis with multiple organ dysfunction syndrome

Waring, W.S.; Wharton, S.B.; Grant, R.; Mcintyre, M., 1999:
Angiotropic large B-cell lymphoma with clinical features resembling subacute combined degeneration of the cord

Evert, M.; Lehringer Polzin, M.; Moebius, W.; Pfeifer, U., 2000:
Angiotropic large-cell lymphoma presenting as pulmonary small vessel occlusive disease

Suzuki, S.; Koizumi, Y., 1997:
Angiotropic lymphoma diagnosed by muscle biopsy

O'Connor, S.R.; Tan, J.H-Y.; Walewska, R.; Brown, L.J.R.; Lauder, I., 2002:
Angiotropic lymphoma occurring in a lacrimal sac oncocytoma

Kobayashi, T.; Munakata, S.; Sugiura, H.; Koizumi, M.; Sumida, M.; Murata, K.; Shinkai, H., 2000:
Angiotropic lymphoma: Proliferation of B cells in the capillaries of cutaneous angiomas

Kumar, A.; Kedar, S.; Garodia, V.K.; Singh, R.P., 2002:
Angle closure glaucoma following pupillary block in an aphakic perfluoropropane gas-filled eye

Halikiopoulos, D.; Serle, J.B., 2001:
Angle closure glaucoma secondary to hemiretinal vein occlusion

Mohamed, Q.; Fahey, D.K.; Manners, R.M., 2001:
Angle closure in fellow eye with prophylactic pilocarpine treatment

Hiro, T.; Leung, C.Y.; Karimi, H.; Farvid, A.R.; Tobis, J.M., 1999:
Angle dependence of intravascular ultrasound imaging and its feasibility in tissue characterization of human atherosclerotic tissue

Wongprasartsuk, S.; Love, R.L.; Cleland, H.J., 2000:
Angle grinder injuries: a cause of serious head and neck trauma

Akiyama, K.; Takazawa, A.; Maeda, T.; Akazawa, T.; Yamanishi, H., 1999:
Angle-adjustable sheath for a dual-stage venous cannula

Dandona, L.; Dandona, R.; Mandal, P.; Srinivas, M.; John, R.K.; Mccarty, C.A.; Rao, G.N., 2000:
Angle-closure glaucoma in an urban population in southern India: The Andhra Pradesh Eye Disease Study

Bernardino, C.R.; Davidson, R.S.; Maus, M.; Spaeth, G.L., 2001:
Angle-closure glaucoma in association with orbital pseudotumor

Steel, R.; Ramnarine, K.V.; Davidson, F.; Fish, P.J.; Hoskins, P.R., 2003:
Angle-independent estimation of maximum velocity through stenoses using vector Doppler ultrasound

Bratty, J.M.; Diewert, R.E.; Irvine, J.; Palermo, V.; Thompson, A.S., 1998:
Angler effort and catch in the 1995 lower Fraser River sport fishery

Walter, A.R.; Palermo, V.; Scott, K.J.; Thompson, A.S., 1998:
Angler effort and catch in the 1996 lower Fraser River sport fishery

Palermo, V.; Thompson, A.S., 1999:
Angler effort and catch in the 1997 lower Fraser River sport fishery

Palermo, V.; Thompson, A.S., 1999:
Angler effort and catch in the 1998 lower Fraser River sport fishery

Palermo, V.; Thompson, A.S., 2000:
Angler effort and catch in the 1998 sport fisheries of five lower Fraser River tributaries

Palermo, V.; Thompson, A.S., 2000:
Angler effort and catch in the 1998 sport fisheries of the Capilano and Squamish Rivers

Kristmanson, J.D., 1999:
Angler effort and catch in the Shuswap River chinook salmon sport fisheries, 1996

Aas, O.; Haider, W.; Hunt, L., 2000:
Angler responses to potential harvest regulations in a Norwegian sport fishery: A conjoint-based choice modeling approach

Lusk, S.; Luskova, V.; Halacka, K.; Smutny, M., 2003:
Anglers catches as an indicator of fish population status

Penczak, T.; Sierakowska, K., 2003:
Anglers' records as a tool for assessing changes in fish populations

Kasuya, H.; Shimizu, T.; Nakaya, K.; Sasahara, A.; Hori, T.; Takakura, K., 1999:
Angles between A1 and A2 segments of the anterior cerebral artery visualized by three-dimensional computed tomographic angiography and association of anterior communicating artery aneurysms

Williams, A., E.; Moss, B., 2001:
Angling and conservation at Sites of Special Scientific Interest in England: Economics, attitudes and impacts

Cockayne, S.E.; Gawkrodger, D.J., 2000:
Angry back syndrome is often due to marginal irritants: A study of 17 cases seen over 4 years

Schwarz, R.; Gunzelmann, T.; Hinz, A.; Braehler, E., 2001:
Angst und Depressivitaet in der ueber 60-jaehrigen Allgemeinbevoelkerung

Teles, M.; Pacheco, M.; Santos, M.A., 2003:
Anguilla anguilla L. liver ethoxyresorufin O-deethylation, glutathione S-tranferase, erythrocytic nuclear abnormalities, and endocrine responses to naphthalene and beta-naphthoflavone

Gonczol, J.; Marvanova, L., 2002:
Anguillospora mediocris sp. nov. from streams in Hungary

England, R.J.A.; Lau, M.; Ell, S.R., 1999:
Angular cheilitis after tonsillectomy

Pintacuda, G.; Hohenthanner, K.; Otting, G.; Mueller, N., 2003 :
Angular dependence of dipole-dipole-Curie-spin cross-correlation effects in high-spin and low-spin paramagnetic myoglobin

Hunter, D.J.; Oganesyan, V.S.; Salerno, J.C.; Butler, C.S.; Ingledew, W.J.; Thomson, A.J., 2000:
Angular dependences of perpendicular and parallel mode electron paramagnetic resonance of oxidized beef heart cytochrome c oxidase

Deardorff, D.L.; Diederich, C.J., 1999:
Angular directivity of thermal coagulation using air-cooled direct-coupled interstitial ultrasound applicators

Nagaratnam, N.; Phan, T.Anh.; Barnett, C.; Ibrahim, N., 2002:
Angular gyrus syndrome mimicking depressive pseudodementia

Butenschoen, I.; Moeller, K.; Haensel, W., 2001:
Angular methoxy-substituted furo- and pyranoquinolinones as blockers of the voltage-gated potassium channel Kv1.3

Ivakhnenko, M.F., 2003:
Angular region of the lower jaw in primitive therapsids

Mikhailov, D.V..; Washington, L.; Voloshin, A.M..; Daragan, V.A..; Mayo, K.H.., 2001:
Angular variances for internal bond rotations of side chains in GXG-based tripeptides derived from (13)C-NMR relaxation measurements: Implications to protein folding

Grass, M.; Koehler, T.; Proksa, R., 2001:
Angular weighted hybrid cone-beam CT reconstruction for circular trajectories

Mason, M.C.; Kerley, G.I.H.; Weatherby, C.A.; Branch, W.R., 2000:
Angulate and leopard tortoises in the Thicket Biome, Eastern Cape, South Africa: Populations and biomass estimates

Dumontel, C.; Rousselle, C.; Guigard, M.P.ule; Trouillas, J., 1999:
Angulate lysosomes in skin biopsies of patients with degenerative neurological disorders: High frequency in neuronal ceroid lipofuscinosis

Morris, C.A.; Verkerk, G.A.; Wilson, J.A., 1999:
Angus selection herd reproductive data: A genetic model for dairy cattle?

Heinz, A., 1999:
Anhedonia - A general nosology correlation of a dysfunction of the dopaminergic reward system?

Romney, D., M.; Candido, C., L., 2002:
Anhedonia and schizophrenia: A reply to Gwenole Loas

Silver, H.; Shlomo, N., 2002:
Anhedonia and schizophrenia: How much is in the eye of the beholder?

Schurhoff, F.; Szoke, A.; Bellivier, F.; Turcas, C.; Villemur, M.; Tignol, J.; Rouillon, F.; Leboyer, M., 2003:
Anhedonia in schizophrenia: A distinct familial subtype?

Loas, G.; Boyer, P.; Legrand, A., 1999:
Anhedonia in the deficit syndrome of schizophrenia

Bydlowski, S.; Corcos, M.; Consoli, S., M.; Paterniti, S.; Laurier, C.; Chambry, J.; Loas, G.; Jeammet, P., 2002:
Anhedonie et conscience emotionnelle: Realites et perspectives dans les troubles des conduites alimentaires

Carrol, E.D.; Gennery, A.R.; Flood, T.J.; Spickett, G.P.; Abinun, M., 2003:
Anhidrotic ectodermal dysplasia and immunodeficiency: the role of NEMO

Mccluskey, A.; Keane, M.A.; Mudgee, L.M.ree; Sim, A.T.R.; Sakoff, J.; Quinn, R.J., 2000:
Anhydride modified cantharidin analogues. Is ring opening important in the inhibition of protein phosphatase 2A?

Mccluskey, A.; Bowyer, M.C.; Collins, E.; Sim, A.T.R.; Sakoff, J.A.; Baldwin, M.L., 2000:
Anhydride modified cantharidin analogues: Synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activity

Shaaya, O.; Magora, A.; Sheskin, T.; Kumar, N.; Domb, A.J., 2003:
Anhydride prodrugs for nonsteroidal anti-inflammatory drugs

Lapinski, J.; Tunnacliffe, A., 2003:
Anhydrobiosis without trehalose in bdelloid rotifers

Ricci, Claudia, 1998:
Anhydrobiotic capabilities of bdelloid rotifers

Tunnacliffe, A.; García de Castro, A.; Manzanera, M., 2002:
Anhydrobiotic engineering of bacterial and mammalian cells: is intracellular trehalose sufficient?

García D.C.stro, A.; Bredholt, H.; Strøm, A.R.; Tunnacliffe, A., 2000:
Anhydrobiotic engineering of gram-negative bacteria

Grellepois, F.; Chorki, F.; Crousse, B.; Ourévitch, Mèle.; Bonnet-Delpon, Dèle.; Bégué, J-Pierre., 2002:
Anhydrodihydroartemisinin and its 10-trifluoromethyl analogue: access to novel d-ring-contracted artemisinin trifluoromethyl ketones

Chen, Y.; Buck, J.; Derguini, F., 1999:
Anhydroretinol induces oxidative stress and cell death

Latenser, B.A.; Lucktong, T.A., 2000:
Anhydrous ammonia burns: case presentation and literature review

Precht, D.; Molkentin, J.; Froidmont Goertz, I.D., 1998:
Anhydrous butterfat reference material CRM 519: Certification of triglyceride composition and cholesterol content including homogeneity and stability tests

Hama, Y.; Nakagawa, H.; Sumi, T.; Xia, X.; Yamaguchi, K., 1999:
Anhydrous mercaptolysis of agar: An efficient preparation of 3,6-anhydro-L-galactose diethyl dithioacetal

Igarashi, Y.; Sekine, A.; Fukazawa, H.; Uehara, Y.; Yamaguchi, K.; Endo, Y.; Okuda, T.; Furumai, T.; Oki, T., 2002:
Anicequol, a novel inhibitor for anchorage-independent growth of tumor cells from Penicillium aurantiogriseum Dierckx TP-F0213

Hopper, Stephen, D., 2003:
Anigozanthos rufus: Haemodoraceae

Kim, Y.C.; Ji, X.; Melman, N.; Linden, J.; Jacobson, K.A., 2000:
Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors

Bebernitz, G.R.; Aicher, T.D.; Stanton, J.L.; Gao, J.; Shetty, S.S.; Knorr, D.C.; Strohschein, R.J.; Tan, J.; Brand, L.J.; Liu, C.; Wang, W.H.; Vinluan, C.C.; Kaplan, E.L.; Dragland, C.J.; DelGrande, D.; Islam, A.; Lozito, R.J.; Liu, X.; Maniara, W.M.; Mann, W.R., 2000:
Anilides of (R)-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase

Tang, J.; Shewchuk, L.M.; Sato, H.; Hasegawa, M.; Washio, Y.; Nishigaki, N., 2003:
Anilinopyrazole as selective CDK2 inhibitors: Design, synthesis, biological evaluation, and X-ray crystallographic analysis

Morgan, J.; Haritakul, R.; Keller, P.A., 2003:
Anilinopyrimidines as novel antituberculosis agents

Wright, S.W.; Carlo, A.A.; Carty, M.D.; Danley, D.E.; Hageman, D.L.; Karam, G.A.; Levy, C.B.; Mansour, M.N.; Mathiowetz, A.M.; Mcclure, L.D.; Nestor, N.B.; Mcpherson, R.K.rk; Pandit, J.; Pustilnik, L.R.; Schulte, G.K.; Soeller, W.C.; Treadway, J.L.; W., 2002:
Anilinoquinazoline inhibitors of fructose 1,6-bisphosphatase bind at a novel allosteric site: Synthesis, in vitro characterization, and X-ray crystallography

Genova-Fuster, Mar, 2000:
Anillos de crecimiento y anos caracteristicos en el Sistema Central (Espana) durante los ultimos cuatrocientos anos

Topps, J.H., 1999:
Animal Science in Zimbabwe: Strategies and solutions

Tidemann, C.R.; Vardon, M.J., 2002:
Animal Welfare v Wildlife Research?

Barnes, R.S.K.; D.V.lliers, C.J., 2000:
Animal abundance and food availability in coastal lagoons and intertidal marine sediments

Beukema, J.J.; Cadee, G.C., 2001:
Animal abundance and food availability: Some comments

Chen, Song Xi, 2000:
Animal abundance estimation in independent observer line transect surveys

Gillbank, Linden, 2001:
Animal acclimatisation: McCoy and the menagerie that became Melbourne's zoo

Donnison, A.M.; Ross, C.M., 1999:
Animal and human faecal pollution in New Zealand rivers

Schultz, M., J.; Van-Der-Poll, T., 2002:
Animal and human models for sepsis

Winokur, P.L.; Brueggemann, A.; DeSalvo, D.L.; Hoffmann, L.; Apley, M.D.; Uhlenhopp, E.K.; Pfaller, M.A.; Doern, G.V., 2000:
Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase

Fabbri, M.; Delp, G.; Schmidt, O.; Theopold, U., 2000:
Animal and plant members of a gene family with similarity to alkaloid-synthesizing enzymes

Ciemerych, M.A.; Mesnard, D.; Zernicka-Goetz, M., 2000:
Animal and vegetal poles of the mouse egg predict the polarity of the embryonic axis, yet are nonessential for development

Andreu, D.; Rivas, L., 1999:
Animal antimicrobial peptides: an overview

Shivik, J.A.; Gruver, K.S., 2002:
Animal attendance at coyote trap sites in Texas

Chhabra, M.; Ichhpujani, R.L., 2003:
Animal bites: the current management guidelines

Brem, Gottfried, 1998:
Animal breeding and genetics in connexion of scientific and social challenges

Chandran, K.; Nibert, M.L., 2003:
Animal cell invasion by a large nonenveloped virus: Reovirus delivers the goods

Mitsuhara, I.; Malik, K.A.; Miura, M.; Ohashi, Y., 1999:
Animal cell-death suppressors Bcl-x(L) and Ced-9 inhibit cell death in tobacco plants

Church, Russell, M., 2001:
Animal cognition: 1900-2000

Longhurst, R.D.; O'connor, M.B.; Bremner, K.; Matthews, L., 2000:
Animal constraints to pasture treated with farm dairy effluent: Preference under grazing and issues of faecal contamination

Dugatkin, L.Alan., 2003:
Animal cooperation among unrelated individuals

Zeitlin, S.G.; Sullivan, K.F., 2001:
Animal cytokinesis: Breaking up is hard to do

Obrink, K.J.; Rehbinder, C., 2000:
Animal definition: a necessity for the validity of animal experiments?

Burrell, Alison, 2002:
Animal disease epidemics: Implications for production, policy and trade

Brooker, L.; Brooker, M.; Cale, P., 1999:
Animal dispersal in fragmented habitat: Measuring habitat connectivity, corridor use, and dispersal mortality

Fraser, David, 1999:
Animal ethics and animal welfare science: Bridging the two cultures

L.Z.guo; Huang Changlin; Liu Jangning, 1999:
Animal experiment and intervention study on the speedup of tibia remodeling

H.X.jing; Cheng Junchang; L.H.openg, 1999:
Animal experiment of the function changes of cauda equina by tracted lumber vertebrae

Yang Dazhi; L.L.ping; Gao Peiguo, 1999:
Animal experimental study of the effect of contaminative or infectious environment on anastomosis of small vessels

Gitanjali, B., 2001:
Animal experimentation in teaching: Time to sing a swan song

Kumar, V.; Singh, P.N.; Mishra, B., 2000:
Animal experimentation: a rational approach towards drug development

Veissier, I., 1999:
Animal experimentation: Biological, ethical and legislative elements

Roy, V.; Tekur, U., 2001:
Animal experiments in medical undergraduate curriculum: A teacher student perspective

Nowak, R.; Pfenninger, E., 1999:
Animal experiments regarding the effects of alcohol on the blood pressure of pulmonic circulation

Von-Den-Driesch, A.; Dockner, A., 2002:
Animal exploitation in medieval Siraf, Iran, based on the faunal remains from the excavations at the Great Mosque (seasons 1966-1973)

Thomas, A.L.; Taylor, G.K., 2002:
Animal flight dynamics I. Stability in gliding flight

Taylor, G.K.; Thomas, A.L.R., 2002:
Animal flight dynamics II. Longitudinal stability in flapping flight

Van Der Zijpp, A.J., 1999:
Animal food production: The perspective of human consumption, production, trade and disease control

Cardellino, R.A., 2000:
Animal genetic resources in southern Brazil

Beecham; Farnsworth, 1999:
Animal group forces resulting from predator avoidance and competition minimization

Wilson, R.T., 2003:
Animal health and disease control in the Usangu Wetland of Southwestern Tanzania

Tenhagen, B.A.; Hoffmann, A.; Heuwieser, W., 1998:
Animal health and economic aspects of organically farmed beef suckler herds in Brandenburg

Hovi, M.; Sundrum, A.; Thamsborg, S.M., 2003:
Animal health and welfare in organic livestock production in Europe: Current state and future challenges

Hashim, H.D., 1999:
Animal health emergencies: prevention and preparedness in Asia

Cabaret, Jacques, 2003:
Animal health problems in organic farming: Subjective and objective assessments and farmers' actions

D.Alwis, M.C.L., 1998:
Animal health research in Sri Lanka: A review of the past, future priorities and constraints

Morey-Holton, E.R.; Halloran, B.P.; Garetto, L.P.; Doty, S.B.; Morey-Holton, E.R., 2000:
Animal housing influences the response of bone to spaceflight in juvenile rats

Seufert, H., 1999:
Animal husbandry between the laws for animal protection and pollution control

Letsoalo, S.S.; Krecek, R.C.; Botha, C.A.; Ngetu, X., 2000:
Animal husbandry in Moretele 1 of North-West Province: implications for veterinary training and research

Eradus, W.; Jansen, M., 1999:
Animal identification and monitoring

Rossing, Wim, 1999:
Animal identification: Introduction and history

Vitiello, D.J.; Thaler, A.M., 2001:
Animal identification: links to food safety

Hayashi, K.; Teramoto, N.; Akagi, T., 2002:
Animal in vivo models of EBV-associated lymphoproliferative diseases: special references to rabbit models

Saldiva, P.H.lario Nascimento; Bohm, G.M.klos, 1998:
Animal indicators of adverse effects associated with air pollution

Froslie, A.; Teige, J., 1998:
Animal killing for humane reasons

Kitaguchi, Katsuya, 2000:
Animal learning and behavior in the irrelevant situation

Healy, S.D.; Jones, C.M., 2005:
Animal learning and memory: an integration of cognition and ecology

Kilpatrick, David, C., 2002:
Animal lectins: A historical introduction and overview

Garesse, R.; Vallejo, C.G., 2001:
Animal mitochondrial biogenesis and function: A regulatory cross-talk between two genomes

Boore, Jeffrey, L., 1999:
Animal mitochondrial genomes

Fan, Y-Ping.; Puri, R.N.; Rattan, S., 2002 :
Animal model for angiotensin II effects in the internal anal sphincter smooth muscle: mechanism of action

Pietilae, T.A.; Zabramski, J.M.; Thellier-Janko, A.; Duveneck, K.; Bichard, W.D.; Brock, M.; Spetzler, R.F., 2000:
Animal model for cerebral arteriovenous malformation

Paulsen, F.P.; Föge, M.; Thale, A.B.; Tillmann, B.N.; Mentlein, R., 2002:
Animal model for the absorption of lipophilic substances from tear fluid by the epithelium of the nasolacrimal ducts

Ravnik-Glavac, M.; Cerar, A.; Glavac, D., 2000:
Animal model in the study of colorectal carcinogenesis

Hayakawa, M.; Taguchi, H.; Kamiya, S.; Fujioka, Y.; Watanabe, H.; Kawai, S.; Kobayashi, H., 2002:
Animal model of Mycoplasma pneumoniae infection using germfree mice

Yuki, N.; Yamada, M.; Koga, M.; Odaka, M.; Susuki, K.; Tagawa, Y.; Ueda, S.; Kasama, T.; Ohnishi, A.; Hayashi, S.; Takahashi, H.; Kamijo, M.; Hirata, K., 2001:
Animal model of axonal Guillain-Barre syndrome induced by sensitization with GM1 ganglioside

Yokozawa, T.; Nakagawa, T.; Wakaki, K.; Koizumi, F., 2002:
Animal model of diabetic nephropathy

Berns, T.; Quang, T.H.; Althoff, J.; Quint, P.; Richter, K.D., 1999:
Animal model of experimentally induced ectopic enchondral ossification in nude mice with xenograft of porcine epiphyseal cartilage

Carson, R.P.; Appalsamy, M.; Diedrich, A.; Davis, T.L.; Robertson, D.; Robertson, D., 2001:
Animal model of neuropathic tachycardia syndrome

Tsutsumi, S.; Kuwano, H.; Morinaga, N.; Shimura, T.; Asao, T., 2001:
Animal model of para-aortic lymph node metastasis

Pappert, E.J.; Goetz, C.G.; Vu, T.Q.; Ling, Z.D.; Leurgans, S.; Raman, R.; Carvey, P.M., 1999:
Animal model of posthypoxic myoclonus: effects of serotonergic antagonists

Yamamoto, T.; Takagawa, S.; Katayama, I.; Yamazaki, K.; Hamazaki, Y.; Shinkai, H.; Nishioka, K., 1999:
Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma

Yamamoto, T.; Takahashi, Y.; Takagawa, S.; Katayama, I.; Nishioka, K., 1999:
Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice

Yamamoto, T.; Kuroda, M.; Nishioka, K., 2000:
Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains

Yamamoto, T.; Nishioka, K., 2002:
Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma

Ludgate, M., 1999:
Animal model of thyroid-associated orbitopathy

Andes, D.; Craig, W.A., 2002:
Animal model pharmacokinetics and pharmacodynamics: A critical review

Ueda, H.; Inoue, M., 2001:
Animal models and peripheral nociception tests for the study of neuropathic pain

Michell, A.R., 2002:
Animal models can assist medicine in humans

Saikku, P.; Latinen, K.; Leinonen, M., 1998 :
Animal models for Chylamydia pneumoniae infection

Yamamoto, M.; Nakajima, O., 2000:
Animal models for X-linked sideroblastic anemia

Smith, D.; Wiegeshaus, E.; Balasubramanian, V., 2000:
Animal models for experimental tuberculosis

Nedrud, John, G., 1999:
Animal models for gastric Helicobacter immunology and vaccine studies

Coenen, A.M.L.; Drinkenburg, W.H.I.M., 2002:
Animal models for information processing during sleep

Martini, Rudolf, 2000:
Animal models for inherited peripheral neuropathies: Chances to find treatment strategies?

Green, S.L.; Tolwani, R.J., 1999:
Animal models for motor neuron disease

Allamand, V.; Campbell, K.P., 2000:
Animal models for muscular dystrophy: valuable tools for the development of therapies

Sandhu, H.S.; Khan, S.N., 2002:
Animal models for preclinical assessment of bone morphogenetic proteins in the spine

Larsson, N.G.ran; Rustin, P., 2001:
Animal models for respiratory chain disease

Spirito, F.; Charlesworth, A.; Linder, K.; Ortonne, J-Paul.; Baird, J.; Meneguzzi, G., 2002:
Animal models for skin blistering conditions: absence of laminin 5 causes hereditary junctional mechanobullous disease in the Belgian horse

Tablin, F.; Walker, N.J.; Klein, S.D.; Field, C.L.; Crowe, J.H., 2000:
Animal models for studies on cold-induced platelet activation in human beings

Mizusawa, H.; Ishizuka, O.; Nishizawa, O., 2002:
Animal models for studying penile hemodynamics

Ogren, S.O.; Misane, I., 1998:
Animal models for studying serotonin (5-HT) receptor subtypes: Relationship to 5-HT system pathologies

Ellenbroek, B.A.; Cools, A.R., 2000:
Animal models for the negative symptoms of schizophrenia

Gambarana, C.; Scheggi, S.; Tagliamonte, A.; Tolu, P.; D.M.ntis, M.G.aziella, 2001:
Animal models for the study of antidepressant activity